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ABSTRACT 
  
Terbinafine HCl, belonging to the allyl amine family, was formulated in a cream dosage 
forms to be equivalent quantitavely and qualitatively to the brand product; Lamisil 
cream. manufactured by Novartis, Pharma AG Basle, Switzerland. The active material 
is Terbinafine HCl. It is a broad-spectrum Antifungal agent. The assay method was 
developed and validated for accuracy, precision, selectivity, linearity, and ruggedness. 
The stability of the selected formula was studied. The prepared cream was compared 
with Lamisil cream penetration. Terbinafine HCl is slightly soluble in water. Triangular 
phase diagram was developed to point the Terbinafine HCl solubility regions in the 
diagram. The components of the diagram are water, terbinafine HCl, and tween 80.  
 
Several trials were carried out to develop a stable, effective, pure, and safe cream. The 
process concentrated on two different paths; first: selecting the best kind and quantity of 
excepients specially the emulsifying agents and the preservatives. Second: changing in 
the mixing techniques. It is important to produce a cream having similar properties like 
the brand cream, such as pharmaceutical, chemical, microbiological, and physical 
properties. Many emulsifiers were tried separately or joint, such as Glycerel mono 
stearate (SE) Eumulgin B2 and cetostearyl alcohol so as to examine all their possible 
uses. At the same time, many trials were carried out to select the most effective and 
safest preservative(s). Change in the step-by-step procedure such as changing speed of 
mixing as to be 20, 80, 120, and 180 °c or changing the temperature before addition of 
the active material to the cream. No sources were available for Terbinafine HCl analysis 
in the pharmacopias (USP, BP &EP), therefore, it was necessary and essential to 
develop assay method for raw material and finished product. HPLC method was 
developed using RP18 as a stationary phase, methanol and acetate buffer (95: 5 
respectively) were used as the mobile phase. The method was validated for the purpose 
of acquiring a high degree of assurance i.e. the applied/adopted method worked 
consistently to determine the product assay. 
Five main validation parameters were examined in this thesis: 
 
- Accuracy was determined by calculating the percent of recovery for three batches. 
Each batch was analyzed three times, where; five injections were carried out for each 
batch. The average values were determined and compared with the true value. 
 
- The Precision was determined by calculating the variation coefficient for three 
different batches, each batch was analyzed three times, where, five injections were 
carried out for each batch. 
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- Selectivity was checked to ensure the absence of interference between the active and 
the excipients. It was tested by analyzing the cream with placebo sample. 
 
- Ruggedness was also checked to verify that the method is working under a variety of   
normal testing conditions. Ruggedness was determined by keeping the prepared 
samples at  different times (15 & 180 min), and at different temperatures (20 °c & 40 
°c) for three batches, it was also determined by using two different columns having the 
same properties. The accuracy and precision were determined for three batches. 
 
- Linearity was also tested to ensure a proportional between the analytical results. It was 
carried out by analyzing 5 different concentrations (50%, 75%, 100%, 125%, and 
150% of method concentration) and plotting the results (in excel sheet) to calculate the 
correlation coefficient of the regression line.  
 
The selected formula was checked for stability. An accelerated stability study method 
was applied. The cream was studied for a period of six months. The cream was kept 
under a temperature of 40 °c and a humidity of 75% for 1,2,3 and six months followed 
by complete analysis to ensure no chemical, physical, or microbiological changes may 
occur. 
 
Penetration of the cream was compared with that for the brand product „Lamisil‟ by 
using the Franz diffusion cell apparatus. It was found that the two formulas have 
approximately the same penetration profile.     
 
Solubility of Terbinafine HCl was determined by addition of Terbinafine to a mixture of 
water and Tween 80. Many mixtures were prepared and plotted into a ternary phase. Wt 
of each sample was about 2.5 gm in 5 ml test tube.  The test tube containing the final 
mixture was followed by proper mixing, sonication, and storage at 25 °c for 24 hours. 
The sample was allowed to settle and its clarity was observed. A mixture that showed 
cloudiness or had a precipitate was considered "two phases". At the same time regions 
of single-phase systems, liquid crystal systems and gels systems were determined for the 
ternary system used. After plotting the phase diagram, the solubility boundaries were 
determined for Terbinafine in the mentioned system. At the same time, regions of 
single-phase systems of micelles and inverse micelles in addition to hexagonal liquid 
crystal systems were determined for the ternary system used. 
 
A good formula for Terbinafine cream was produced. It was equivalent to the Lamisil 
cream according to the chemical, physical, microbiological, and pharmaceutical 
properties. The selection of emulsifying agents was a mixture of Glycerel Mono 
Stearate (SE), Eumulgin B2 and Cetostearyl alcohol. The selected preservative was 
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chloro-cresol, which was active against the organisms mentioned in the USP. The other 
preservatives failed to do that or caused problems for the analysis. It was also found that 
the best speed of mixing was between 80 and 120 rpm to avoid air bubbles or phases 
separation. Addition of Terbinafine at 50, 60, or 70 °c did not show any difference, 
which means that Terbinafine HCl was stable under high temperatures 50 °c - 70 °c.  
 
The developed method of analysis was found valid for all parameters tested.  
 
The selected formula was stable under accelerated stability study at condition of 40 c & 
75 %RH, it can be given an expiry date of 2 years. The solubility of Terbinafine HCl 
was found is slightly soluble in water and Tween 80 (i.e. < 1 gm/100 solvent). The 
drawn phase diagram detected the soluble area of Terbinafine HCl in the mixtures that 
form the phase diagram. Simultaneously, the phase diagram showed the other areas of 
hexagonal liquid crystal, micelles, and inverse micelles in addition to the two phases 
regions.  
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1- INTRODUCTION 
  
1-1 Formulation 
 
Creams are semisolids emulsion systems. Like all other dosage forms, creams must be 
formulated, manufactured and packaged in a manner to ensure that they meet general 
standards of bioavailability, physical stability, chemical stability and freedom from 
contamination and elegance. These factors must essentially remain invariant and 
reproducible from batch to batch (1).  
 
Formulation of drugs into transdermal dosage form requires interpretation and 
application of wide range of information from several study areas. The physical, 
chemical and pharmaceutical properties of drugs and additives need to be understood, 
the factors influencing drug absorption and the requirements of the disease also have to 
be taken into account when identifying potential delivery routs (2). The formulation 
requires evaluation of wide information such as the selected materials, analysis, 
equipment, in addition to the ecconomic aspects. 
 
Formulation of a generic new product requires following some important steps that are 
necessary to produce the  required product. These steps can be summarized as the 
following: 
 
1- Data collection for the brand product   
2- Data collection for the active material used 
3- Data collection for the additives may be used 
4- Equipment selection 
5- Selection of additives and preparation of suggested master formulas 
6- Manufacturing of finished product (trials) 
7- Development of analysis methods for the active material, brand product and the 
generic drug product. 
8- Validation of analysis method (assay) 
9- Stability study (accelerated and long term) 
10- Improvement on the selected master formula (if necessary). 
 
Data collection of the active material is a very important step. It includes the chemical, 
physical, pharmaceutical and general properties of substance. Effective information may 
lead to produce a stable, effective and safe dosage form. Data collection includes but is 
not limited to the following: 
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Organoleptic properties (color, odor, appearance…) 
Particle size  
Solubility characteristic in many solvents 
pH and temperature stability profiles 
Additives interactions 
Manufacturer of the active material 
Material cost and availability. 
 
Data collection of the brand product is also a very vital step. It includes but is not 
limited to the following  the chemical, physical and pharmaceutical properties of the 
product such as: 
 
pH   
Penetration 
Smoothness 
Stability 
Viscosity 
Color 
Odor 
Local irritation 
Application site 
Formulation additives 
Analysis and analytical validation, and 
Safety study. 
 
The most time consumed for creating a new formula is selecting the product excipients 
and their specifications. Data collection should be done carefully. The following are 
some factors  that must be taken into consideration before materials selection 
 
1- Material effectivness 
2- material cost 
3- ease of using 
4- toxicity 
5- ease of analysis 
6- availability 
7- purity, odor, color 
8- incompatibility 
9- particle size, and 
10- stability. 
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There are many available excipients sharing the same function that can be used for 
Terbinafine cream formulation. Many trials are to be performed to select the appropriate 
materials. The following is a summary of these materials described in Table [1-1]. 
  
Table [1-1] Suggested excipients that are necessary for Terbinafine cream manufacturing 
Function Materials 
Emulsifying agent Glycerel mono stearate (SE), Eumulgin B2  
Auxiliary Emulsifying agent Cetostearyl alcohol 
Emollient Liquid paraffin, lanolin 
Solvent  Alcohol, water 
Alkalizing agent TEA. NaOH,  
Acidifying agent Citric acid, HCl (0.2M) 
Preservative Mp, pp, chlorocresol, phenoxy ethanol 
Base Vaseline white 
Continuous phase Water  
 
Emulsifying agent selection is restricted to the cream stability and the brand product 
viscosity. The alkalizing agent/acifying agent type and quantity are restricted to the 
brand product pH. The base quantity is also confined to the viscosity and the cream 
stability.  Preservative selection is critical to many factors such as; pH (cream), 
preservative concentration, solubility, sensitivity to the required micro-organisms, 
toxicity and environmental factors. All materials are restricted to their cost. 
 
                                                                              
The best formula for producing a cream is the one that pass all the tests related to the 
sem1-solids preparations. Table [1-2] shows the most important characteristics.  
 
Equipment used in the manufacturing , processing, packing or holding of a drug product 
shall be of appropriate design and adequate size. Selection of equipment is an important 
subject. Many considerations should be taken before their selection such as criteria, 
availability of spares, maintenance, environmental issues, construction material and 
design, availability of process control, and the comprehensive cost (3). 
 
For creams, there are two applied techniques, oil/water or water/oil depending on many  
factors (4) such as:  
 
a- The order of mixing may determine what type of emulsion forms.  
b- The nature of the emulsifier. If the emulsifier is more oil soluble, a W/O is more 
likely whereas a more water soluble one makes O/W emulsions more likely. 
c- The volume ratio of the oil and water.  
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d- The phase in which you initially dissolve the emulsifying agent. 
e- The temperature of the system. if you increase the temperature on an emulsion made 
with nonionic surfactants, if you start with an O/W emulsion, it may well invert to a 
W/O. 
f- The amount of electrolyte,  increased electrolyte decreases repulsion and makes the 
head groups less hydrophilic.  
 
Table [1-2] Summary for the most important tests should the cream pass 
Tests Limit  
Physical stability No separation after centrifusion 
Tackiness Untacky cream after application 
Greasiness No Grease remaining on skin after application 
Viscosity + 10% of brand product viscosity 
Appearance of applied film Transparent after application 
Skin allergies (irritation) No irritation after application 
Assay  90.0 – 110.0 % of labeled amount 
pH + 0.2 of brand product pH 
Smoothness  Smooth on skin  after application 
Microbial contamination Total count<1000 cfu/g, free from Staphylococcus 
a., and Pseudomonas a.) 
Organoleptic  properties Homogeneous white cream, free from air bubbles, 
the smell should be acceptable 
 
Many trials may be carried out, The following are some ideas that aid the formulator to 
achieve his/her purpose in the shortest time 
 
-Changing  type and quantity of the emulsifying agent. 
-Using more than emulsifying agent at the same time 
-Addition of auxiliary emulsifying agent 
-Changing type of preservative and using more than one preservative at the same time. 
-Changing speed of mixing for oil phase with aqueous phase. 
-Addition of active material at different temperatures (50 °c -70 c). 
 
1-2- Therapeutic Action 
 
Terbinafine is the first member of a new class of antifungal agents, the allylamines, 
became available for the topical use (5). It composed of naphthalene group, allyl amine 
group, in addition to a triple bond between two carbon atoms as shown in figure [1-1].  
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Figure [1-1] Chemical structure for Terbinafine  
 
 
It has rapid responses in dermatophyte (tinea) infections, higher than the older topical 
antifungals such as nystatin and natamicin. The cure needs shorter period of treatment. 
It is very lipophilic, remaining in the stratum corneum for seven days after application, 
so it has advantages over many antifungals such as Imidazoles (Ticonazole, Econazole, 
Ketoconazole, Miconazole, Clotrimazole), Morphines Ciclopiroxolamine, and 
Thiocarbamate (5,6,7). 
 
The antifungals agents act by blocking of some steps needed to build the fungus 
membrane (7). Terbinafine acts by inhibiting the fungal enzyme, squalence epoxidase 
that is necessary to build the cell membrane by stop making of the ergosterol (the main 
component of the cell wall). The accumulation of squalence within the cell is toxic to 
the organism (5,6,8). 
 
 Terbinafine is a broad-spectrum antifungal. It is used to treat fungal infections of the 
nails. In addition to the treating of dermatophyte that cause skin infections known as 
„Ringworm‟, it is also used to treat yeasts infections of the skin which are another type 
of fungus. A common example of the yeasts is the candida albicans. Terbinafine has 
fungicidal effect by killing dermatophytes and killing or stopping the yeast growth to be 
as fungicidal and fungistatic at the same time depending on the species, for example; it 
is fungistatic against candida albicans (6,9,10, 11). 
 
Antifungals agents do not produce instant results. So Terbinafine (as cream) does not act 
full effect before 2 – 6 weeks but the primary result can be taken after a week of 
application. The cream is used for ringworm of the foot (athlete‟s foot), ringworm of the 
groin (jock itch), and ringworm of the body (tinea corporis), tinea versicolor (sun 
fungus) and yeast infection of the skin (cutaneous candidiasis but for fungus of the 
toenail or finger nail the tablets are preferred (12).  
Terbinafine can be used for onychomycosis.  Onychomycosis refers to fungal infection 
of the nail caused by dermatophytes, yeasts, and nondermatophytic moulds. It accounts 
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for one third of fungal skin infections; at the same time it accounts for one-half of all 
nail disease. (13,14).  
 
Terbinafine cream is applied gently twice daily for one week for Tinea Pedis treatment, 
one to two weeks for Tinea Corporis and Cutaneous Candidiasis and for two weeks for 
Pityriasis Versicolor treatment. Before applying of the cream, the affected area should 
be cleaned and dried well. It is possible to cover the infected area by using a suitable 
gauze after applying the cream specially at bed time. The hands should be washed well 
after using the cream. The cream is kept away from eyes, nose, mouth and other mucous 
membranes. (15,16). Another source of information (5) considers applying the cream 
once daily is enough, because the drug appears in high concentrations in the skin, and 
the half life is about 16-17 hours.  
 
Terbinafine brand product is called Lamisil supplied as tablets, solution and cream 
manufactured by Novartis company.  
 
1-3-Analysis 
 
There are many tests for analyzing the drug. The type of the test applied depends on the 
drug dosage form. The aim of the analysis is to check GMP (Good Manufacturing 
Practice) compliance of the drug ie.„ effectiveness, purity and safety‟  
 
Analysis of creams , like other semisolids preparation, requires many necessary tests to 
ensure  that the drug is safe, effective and pure. The following are the most important 
tests: 
 
-Identification 
-Color 
-Assay & degradation  
-Viscosity  
-Content uniformity 
-Stability of phases 
-pH  
-Grittiness 
-Greasiness 
-Skin allergies 
-Tackiness 
-Microbial contamination cfu/g (Total count, Staphylococcus a., and Pseudomonas a.). 
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Most of the modern analytical methods are mainly depending on two principles; 
chromatography and spectroscopy. The first is for separation aims but the second is for 
the detection, so they are used together in many instruments (17). 
 
Many analytical methods are used to determine the assay of the active material 
(Terbinafine as in our case). The most appropriate method is the HPLC method which is 
a method of separation in which the stationary phase is contained in a column, one end 
of which is attached to a source of pressurized liquid eluent or mobile phase (18). HPLC 
can determine the amount of material in the dosage form, at the same time it can be used 
as an identification method for the active and the other product ingredients such as the 
preservatives. HPLC method can detect the materials at small quantities, so it can detect 
the degradation in the products especially for old batches.  
 
The prefered detectors for most separations are the UV/VIS detectors of fixed and 
variable wavelengths. The current UV/VIS detectors are the diod array models that carry 
out detection continuosly at a different wavelengths. For any time point in the 
chromatogram, an absorption spectrum can be displayed from the array storage (19). 
 
Column selection is an important factor for best separation between the compounds. 
Reverse phase columns are useful for most compounds other than the normal phase for 
the drug analysis. For reverse phase, the mobile phase should be polar solvents to cause 
good separation (20). 
 
The method of analysis should be good indicator for the stability studies (21). It must 
detect all impurities that may develop in the drug. At the same time the method of 
analysis should detect some inactive materials (excipients) such as the preservatives and 
the colors . 
  
1-4- Analytical Validation 
 
Validation is an establishing document evidence which provides a high degree of 
assurance that a specific method/process/machine will consistently work to determine 
the product specifications and quality attributes (22). In other words, validation is an 
operation intended to demonstrate that every process and procedure used for production, 
packing, or control of products does actually lead to the expected results (23). 
 
Its importance appeared for the first time in 1971, when some people in the USA died as 
a result of an error in the sterilization process of some bottles of 5% dextrose infusion 
kept in the autoclave.  
1-4-1-Validation Importance 
8 
 
 
There are many benefits that come up from the validation (24). Such benefits include but 
are not limited to the following  
 
1-Manufacturers are required by law to conform to GMP regulation 
2-Good business dictates that a manufacturer avoid the possibility of rejected or recalled 
batches 
3-Validation helps to ensure product uniformity, quality and reproducibility. 
 
1-4-2-Validation Types 
 
There are many types of validation (25) Such types include but not limited to the 
following: 
 
Analytical Methods 
Equipment 
Manufacturing process 
Cleaning 
Sterilization 
Environment 
 
1-4-3-Validation Options 
 
There are three options for validation;  
 
Prospective, retrospective, and revalidation (26). 
 
1-4-3-1- Prospective Validation 
 
Validation done prior to manufacture and distribution  (for new products at development 
stage) from an approved plan and protocol for validation with predefined acceptance 
criteria.  
 
1-4-3-2- Retrospective Validation 
 
Validation based on review and statistical analysis of historical data for a analysis of a 
product over the two previous years at the same time, the total number of batches should 
be between 10 to 50.  
1-4-3-3- Re-Validation 
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There are many cases for re-validation of the method of analysis. Such cases include but 
not limited to the following 
 
- Changes in a critical raw material used in the product 
- Change or replacement in a critical piece of modular (capital) equipment. 
- Sequential batches that fail to meet the product and process specification. 
 
1-4-4-Validation of Raw Materials 
 
The validation process of a cream dosage form begins with a validation of the raw 
materials. Variation in raw materials (active or inactive excipients) is one of the major 
causes of product variation or deviation  from  specification. Each raw material should 
be validated by performing checks on several batches, preferably three. The batches 
chosen should be selected to represent the range of acceptable specifications both high 
and low. The most important parameters are particle size, microbial contamination, 
moisture content, color, pH, impurities and assay (28). 
 
1-4-5- Assay Validation 
 
Unless a suitable analytical methods, or series of methods, are available to assess the 
quality and performance of cream dosage forms, the validation program will have 
limited validity. 
 
1-4-5-1- Analytical Parameters to be Validated 
 
a-Accuracy 
 
Accuracy is the closeness of the test results to the true value(27). It can be determined 
by calculating the percent of recovery on three different batches. Each batch is analyzed 
three  times. 5 injections are carried out for each batch. 
 
b-Precision 
 
Precision is the degree of agreement between the test results (28). It can be determined 
by calculating the variation coeffecient for three different batches. Each batch is 
analyzed three  times. 5 injections are carried out for each batch 
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c- Selectivity 
 
Selectivity is the absence of interference between the analyte and the other components 
(27), and that the expected peak for the active (for HPLC methods) is true. It can be 
determined by comparing the analysis between the product containing the analyte and 
the product without the analyte (placebo). 
 
d-Linearity and Range 
 
Linearity is a proportional relation between the analytical results and its concentration 
through a defined range (27). It can be determined by calculating the correlation 
coefficient of a regression line. At least 5 concentrations should be prepared and tested 
(50%-150%) of normal concentration of analysis method. 
 
e-Ruggedness 
 
Ruggedness is the degree of reproducibility for the same samples under a variety of 
normal test conditions such as time, temperature, column used and others (27). It can be 
determined by analyzing samples kept at different times and temperatures or replacing 
the column with another two colums of the same type followed by measuring the 
precision of the samples kept under these conditions. 
 
1-5- Stability Study 
 
The term stability, with respect to the drug dosage form, refers to the chemical and 
physical integrity of the dosage unit and when appropriate, the ability of the dosage to 
maintain protection against microbiological contamination (29). 
 
A stable cream is one in which the dispersed phase retains its initial character and 
remains uniformity distributed through out the continuous phase (30).  
Although the stable cream is that retain their ingredients with no degradation for all 
components especially the active principle (31). 
 
Stability studies are necessary for all drugs, specially the sem1-solids, because 
instability of the product can produce ineffective drugs by the loss in the assay of active 
principle or decreasing in its bioavailability. The drug product, therefore, has to satisfy 
stability criteria chemically, toxicologically, therapeutically and physically (32)   
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Factors Affecting Product Stability 
 
Stability parameters of a drug dosage form can be influenced by environmental 
conditions of storage such as temperature, light, air and humidity as well as the 
incompatibility between ingredients, manufacturing process, handling, dosage form, and 
packing components reactions (32). Incompatibility can be physical, chemical, and 
pharmaceutical. There are many routes for chemical reactions such as; Oxidation-
reduction, hydrolysis, decarboxylation, recemization, photochemical and others (33). 
 
Modes of Stability Studies 
 
There are many modes for stability study, but the most important modes are (33) 
 
1- Long term stability study  
2- Accelerated stability study  
 
Table [1-3] shows the storage condition for both modes 
 
Table [1-3] Storage condition for long term and accelerated stability study 
Study mode Condition Period 
Long term 25 + 2 °c/60  +5 RH 12 Months 
Accelerated 40 + 2 °c /75 + 5 RH 6 Months 
 
Accelerated studies are designated to increase the rate of chemical degradation or 
physical changes of a drug product by using exaggerated storage conditions as part of 
the formal definitive storage program. Two factors are determined as a result of this 
study Storage conditions and the expiration date.  
 
The expiration date for products is given upon the result of this study, which should  not 
exceed two years, but can be extrapolated according to the results obtained from the 
long term stability studies.  
 
For determination of storage condition; the samples are stored under condition (40 c, 
75% RH) for six months. This will lead to the following: if there is no change, two years 
expiration date is given, with label “store at room temperature”. Because 6 months 
equivalents to 2 years if the product is kept under 40 c as calculated using Arrhenius 
equation. If significant change occurs in this condition, the formula  must be changed 
(35,36).  
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Arrhenius equation (34)             k=A*exp(-Ea
/R*T)  
 
Where k is the rate coefficient, A is a constant, Ea is the activation energy, R is the 
universal gas constant, and T is the temperature (in degrees Kelvin).  
 
To determine the incubation time necessary for stability claims using the Arrhenius 
equation 
  
a) Q10
 
 = 2.0 (conservative; “Rule of Two”.  For every 10 degree increase in temperature 
the rate of degradation doubles) 
b) Room temperature = 20 C (Controlled  room temperature)  
  
c) Real Time = Acceleration Time *Q10
(T2-T1/10)
 
 
T2 , T1, Temperatures at required storage condition and at room temperature 
respectively 
 
Real Time = 6* 
2(40-20)/10
 = 24 months = 2 years 
 
From the chemical structure of Terbinafine (as shown in figure [1-1]), the substance 
composed of naphthalene group, allyl amine group, in addition to a triple bond between 
two carbon atoms. Allyl amine is relatively stable as a result of the resonance effect 
(conjugative effect) due to the overlap between the orbitals but it is responsible  for the 
addition reaction by acidic substrates such as HCl, also for hydrolysis reaction, in 
addition, it is responsible for free radical reaction as a result of reaction with light. 
Naphthalene group is responsible for oxidation reduction reaction by reacting with 
oxidizing agent. The triple bond reacts with the basic materials such as NaOH because it 
is relatively acidic group. 
 
All initial data should be collected and kept to compare results of analysis in the future 
such as assay, color, odor, degradation, pH, tackiness, greasiness, viscosity, skin 
allergies, microbial contamination and physical stability. A minimum of three batches 
are studied. The samples are kept in a cooled incubator.  
1-6- Penetration 
Transdermal and topical formulations permeation involve partitioning into and transport 
through the cutanous layers, namely the stratum corneum, the viable epidermis, and the 
upper dermis. A topical product is designed to deliver the drug into the skin to treat 
dermal disorders and therefore skin is the target organ. The skin is a barrier to topically 
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administer drugs. Although, the outer layers provide resistance to the global permeation 
process (37). 
 
With many drugs, the rate of permeation through the skin is extremely low without the 
use of some means to enhance the permeability of the skin. In order to increase the rate 
at which a drug penetrates through the skin, various approaches have been followed by 
using either a chemical penetration enhancer or a physical penetration enhancer. 
Physical enhancement includes electrophoretic techniques such as iontophoresis, in 
addition to the use of ultrasound. Chemical enhancers are administered along with the 
drug in order to increase the permeability of the stratum. An effective amount of a 
permeation enhancer is meant a non-toxic non-damaging non-irritating, but sufficient 
amount of the enhancer to provide the desired increase in skin permeability and, 
correspondingly, the desired depth of penetration, rate of administration and amount of 
drug deliver. Various compounds for enhancing the permeability of skin are known in 
the art and literature. Compounds that have been used to enhance skin permeability 
include solfoxides, ethers, surfactants, alcohols, fatty acids, fatty terpenes, alkanols, and 
organic acids (38). Chemical enhancer enables the Terbinafine bulky molecules to pass 
through the stratum corneum layer by expanding the paths  of the liquid crystal layer of 
the stratum corneum layer. As shown in figure [1-1], the chemical structure of 
Terbinafine is composed of naphthalene group, allyl amine group and triple bond 
between two carbon atoms. All these groups are electron releasing, that means, it is 
difficult to lose a proton from the molecule, so the material is lipophilic. The material 
remains in the stratum corneum seven days because it is lipophilic (as the most 
composition of the stratum corneum).  
 
The skin structure is composed of several layers (39) as shown in figure [1-2]. 
Epidermis is composed of several layers but the most important layer  
 is “ Stratum Corneum”. It is the limit step layer for the penetration process. It 
composed of protein, lipid and water layers (40), as shown in figure [1-3] 
 
 
 
 
 
 
 
 
                                                                                  
                                                 Figure [1-2] Skin layers  
 
Epidermis 
Dermis 
Hypodermis 
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    Figure[1-3] Stratum corneum layer composition  
 
Penetration Steps 
 
  Drug release from cream 
 
Diffusion through lipid layer of stratum corneum  
 
   Passing through aqueous layer 
 
   Absorption into the blood capillaries of the dermis layer 
 
 
The vehicle of the drug is important factor that it may affect permeability of the drug. In 
this thesis, the penetration of terbinafine HCl will be evaluated by comparing its 
penetration with that for Lamisil cream (the brand product), using Franze Diffusion 
Cell, as shown in figure [1-1], which is made of glass with a constant area of 1.35 cm². 
It is consisted of a donor compartment (A) and a receptor compartment (B). The 
membrane (C) is mounted between the cell compartment and an O-ring (D). The two 
cell compartments are held together with a clamp. The system is kept at 32 c by 
             Lipid layer               Protein layer 
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circulating water through an external water jacket (E). The receptor solution is 
continuously stirred by means of a spinning bar magnet (F). The samples are withdrawn 
through the sampling port (G), (41). 
 
 
 
 
                                             Figure [1-4] France Diffusion Cell. 
A = donor compartment; B = receptor compartment;  C = membrane; D = O-ring;     E = water jacket;     
F = stirring bar; G = sampling port 
1-7- Phase Diagram 
 
An important aim to the thesis in addition to formulation and analysis is establishing a 
triangular phase diagram compositioning of  terbinafine, water and tween 80 to 
determine the solubility of Terbinafine in the two mentioned solvents. Phase diagram is 
an essential tool for designing microemulsion system, liquid crystal systems, or two 
phases systems and in addition to the solubility of materials.  
 
To find the soluble region of Terbinafine HCl in the phase diagram, a proportional 
amount of the substance is added to the two componets mixtures, followed by shaking, 
sonication and storage at 25 °c for 24 hours. The samples are centrifused at 5000 rpm 
for 15 minutes and their physical condition (clarity, ppt, and flowability) is determined. 
Mixtures that did not show any change in the meniscus after tilting to an angle of 90° 
are considerd to be gels (42). Identification of phases can be done visually or by using 
polarized microscope, in addition to other identification methods. 
Appearance of cloudness or precipitation showes beginning of insolubility of the 
substance in the mixtures. 
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Solubility of Terbinafine HCl in water and tween 80 can be determined to be compared 
with the substance solubility in the phase diagram mixtures. Terbinafine HCl is soluble 
in ethanol but slightly soluble in water and tween 80. Terbinafine HCl is soluble in 
alcohols such as ethanol. It is important to find other than alcohols to dissolve the 
material such as the mixtures of tween 80 and water. Alcohols are more expensive than 
water and tween 80, they have chemical activity that can affect product stability, in 
addition to the environmental essues.  
 
Terbinafine HCl is added in excess to both solvents (water and tween 80) separately to 
calculate its solubility in these two solvents. The samples are stored at 25 c° for 24 
hours, then filterd using 0.45 m and analyzed using high performance liquid 
chromatography. 
1-8- Specifications 
1-8-1- Terbinafine Specification 
Material name: Terbinafine HCl 
 
Material Solubility: Terbinafine HCl dissolves in methanol, ethanol, and 0.1 N NaOH. It 
is  slightly soluble in water. 
 
Molecular wt: 327.9 g/mol 
 
Material Source: A synthetic allylamine derivative. 
 
Approved Supplier: Medifarma East 
 
Safety Precautions: Wearing masks, gloves, caps, eyeglasses, the material is kept in 
well-closed containers. 
 
Storage Conditions: It should be protected from heat, moisture and light. 
 
Action And Use: Antifungal.  
 
Tests to be done: Assay, identification, organoleptic properties (appearance, color, odor, 
…), solubility, purity, and moisture content. 
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1-8-2- Finished Product Specification 
1-8-2-1-Specification of brand product 
 
1- Product name: Lamisil 1% cream 
2-Therapeutic action: Broad spectrum antifungal agent. 
3- Composition: 1% Terbinafine HCl 
4- Pharmaceutical form:  Cream 
5- Manufacturer: Novartis, Switzerland 
6- Expiration period: 5 years 
7- How supplied: 15 g / tube 
8- Color of cream: White 
9- Tube Type: Aluminum with plastic cap 
10- Other dosage forms for Lamisil line: Solution and tablets. 
11- Storage: Store in a cool and dry place. 
 
1-8-2-2-Specification of generic product  
 
The specification of the generic product should be identical to the brand product 
according to the effectiveness, viscosity, composition, pH, color and others.    
 
General Specification 
 
1- General appearance Homogeneous white and smooth cream, free from air bubbles. 
Its smell is acceptable. 
2- How supplied 15 g / tube 
3- Expiration period 2 years increased yearly up to 5 years. 
4-Tube Type Aluminum with plastic cap. 
5-Storage Store in a cool and dry place. 
 
1-9- Study Objectives     
 
This thesis has several objectives that can be condensed in the followings: 
 
1- To develop a stable formula for Terbinafine cream followed by stability study to 
produce a cream equivelent to the brand product (Lamisil).  
2- To develop an effective formula for Terbinafine cream and testing its penetration. 
3- To learn more about the function of the excepients that might be used in the    cream 
dosage form by carrying out different trials. 
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4- To develop a method of analysis followed by analytical validation. 
5- To find out the best solubility system for Terbinafine HCl depending on a triangular 
phase diagram technique. 
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2- EXPERIMENTAL 
 
2-1- Analysis of Finished Product & Determination of Brand Product 
Specification 
 
2-1-1-Materials and consumables 
 
Soya bean casein digest agar from Difco Laboratories, Detroit, USA. 
Sodium chloride peptone solution pH 7.0 from Difco Laboratories, Detroit, USA. 
Fluid soybean casein digest medium from Difco Laboratories, Detroit, USA. 
Cetrimide agar medium obtained from Difco Laboratories, Detroit, USA. 
Baird Parker agar medium obtained from Difco Laboratories, Detroit, USA. 
Casein digest agar obtained from Difco Laboratories, Detroit, USA. 
Ammonium acetate obtained from Merck, Germany. 
Methanol HPLC  obtained from Merck, Germany. 
Terbinafine HCl from Cross chem. International Co., Switzerland. 
0.1 N NaOH NaOH obtained from Merck, Germany. 
Milli-pore filter 0.45 m 
Milli-pore filter 0.22 m 
Sterile petri dishes (90 mm) 
Screw- cap sterile tubes 
Test tubes 5-15 ml 
 
2-1-2- Equipment 
 
Balance, Precisa XT 220A    
Vortex, Gennie vortex, scientific industries, USA.   
HPLC Apparatus, Merck Hitachi 
Viscometer, Brockfield, Model DV-2+  
Centrifuge apparatus, Gemmy Industrial corp., serial No. 9104307/99 
Incubator, Ari J-Levy- Israel  
Autoclave (wet),Tuttnauer, Israel 
pH meter, Mettler Toledo, Mp230 
Sonicator, Elma – Transsonic T 780/H        
Karl fisher apparatus, 758 Titrino, Metrohm  
Hot plate with stirrer, Biby Stirilin Ltd, UK, Serial No. CB162/13583  
Spectrophotometer, Hithachi, U2000. 
Incubator, (for stability study) WTB Binder Labortechnik GmbH 
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2-1-3- Tests 
 
2-1-3- 1- Assay 
 
Method: HPLC 
 
Materials Used:  Methanol, 0.1M Ammonium acetate, water, Terbinafine HCl. 
 
Mobile Phase:  95.0% Methanol 5.0%,   0.1M Ammonium acetate.  
 
     To prepare 0.1M ammonium acetate, 0.77 g of ammonium acetate is dissolved in   100 
ml water. 
 
Stationary Phase: RP18, 125*4 mm, 5m 
 
UV-Wavelength (): 223 nm 
 
Flow rate: 1.0 ml/min.  
 
Temperature: Room temperature  
   
Vial volume: 20 l 
 
Standard Preparation 
250.0 mg of Terbinafine HCl is dissolved in about 60 ml mobile phase. The volume is 
completed to 100.0 ml. 1 ml is diluted into 100.0 ml using mobile phase. 
 
Sample Preparation 
0.250 gm of sample is shaked with about 60 ml mobile phase for 20 min. The sample is 
filtered through a Whatman filter paper No. 4. The filter paper is washed by about 30 ml 
mobile phase. The washings are added to the filtrate. The volume is completed to 100.0 
ml using the same solvent. The sample is filtered through a 0.22 m Millipore filter 
paper. 
 
Procedure  
 
The vials for the sample and standard solutions are prepared. The automatic  
procedure is carried out for the pump, injection, detection, presentation, and calculation. 
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Calculation 
 
% Material  = (Sample Peak area/Standard Peak Area ) * 100  
 
Limits 90 + 110 % of the labeled amount of material. 
 
2-1-3- 2- Identification 
 
The retention time of the sample and standard for the active material obtained in the assay 
under the same conditions must be the same or within the  0.1 minute range. 
 
Limit Retention times for sample peak and standard peak should be identical.  
 
2-1-3- 3-Impurities Determination 
    
The same procedures used in the HPLC assay. 
  
HPLC can detect the impurities accurately especially when the retention times are 
prolonged if necessary to aid the resolution by increase the difference of the polarity 
between the mobile phase and the stationary phase. 
 
2-1-3- 4- pH Test 
 
Instrument pH meter 
 
Procedure  
10 g of sample is mixed with 90 ml purified water, the sample is directly measured at 
normal temperature using calibrated pH meter 
 
Limit  + 0.2 of the brand product 
 
2-1-3- 5- Content Uniformity 
 
Procedure  
Three individual samples are tested for the assay; one injection from each sample is 
analyzed.  
 
Limit 85.0% -115.0% of labeled amount. 
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2-1-3- 6- Phase Stability Test (Centrifusion Test) 
 
Time: 15 minutes 
 
Revolution: 5000 Rounds/minute 
 
Procedure  
A quantity of the cream is placed in two parallel centrifuge tubes and rotated at 5000 
/minute for 15 minutes at room temperature. 
 
Limit: No separation is allowed. 
 
2-1-3- 7- Smoothness Test (Grittiness) 
 
Procedure 
A thin layer of the product is applied on the hand and checked for the smoothness and 
the absence of any particles. 
 
Limit: The cream must be smooth. 
 
2-1-3- 8- Organoleptic Properties 
 
The color, odor, and general appearance of the cream are determined. 
 
Limit  
 
Odor acceptable and identical to the standard  
Color white 
General appearance no air bubbles, no impurities, homogeneity availability. 
 
2-1-3- 9-Tackiness Test 
 
A thin layer of the product is applied on the hand and checked for the absence of 
tackiness. 
 
Limit:  Untacky cream is required. 
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2-1-3- 10-Greasiness Test 
 
A thin layer of the product is applied on the hand and checked for the absence of grease 
on skin. 
 
Limit:  No grease remains after cream application. 
 
2-1-3- 11- Appearance of Applied Film Test 
 
A thin layer of the product is applied on the hand and checked for the transparency of 
the applied film cream. 
  
Limit: The applied film cream should be transparent to the skin. 
 
2-1-3- 12- Skin Allergies Test 
 
A thin layer of the product is applied on the hand and checked for the absence of an 
irritation on skin. 
 
Limit:  No irritation is allowed. 
 
2-1-3- 13- Viscosity 
 
About 50 g of the finished product are measured using Brookfield viscometer 
 
Time: after 1 hour under the viscometer,  
Spindle: T-bar spindle with length of 10.9 mm  
Speed:  30 rpm, 
Temperature: room temperature 
Limit: + 10% of brand product 
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2-1-3- 14- Microbial Analysis 
 
Reference: USP 24 
 
a-Total Count 
 
1-Method Filtration method  
 
2-Media Preparation 
 
Suspend 40 g of the Soya bean casein digest agar in 1L of purified water mix 
thoroughly, heat with frequent agitation, and boil for 1 min to dissolve the powder, 
autoclave at 121.0 c for 15 min. 
  
3- Sample Preparation  
 
Dissolve 1.0 g of the product in 10 ml buffered sodium chloride peptone solution pH 
7.0.  
 
4-Procedure 
 
- Use membrane filter having a nominal pore size of 0.45 m. 
- Pass the sample through the membrane filter. 
-Wash the filter with 100 ml of buffered sodium chloride peptone pH 7.0 for 3 times.  
- Transfer one membrane filter for Soya bean. Casein digest agar for the enumeration of 
bacteria and incubate at 35-37 c for 48 hours. 
- Calculate the no of cfu /gm. 
 
5- Limit : Total viable aerobic count < 1000 cfu /gm   
 
b- Staphylococcus aureus 
 
Method: spread plate method 
 
 Procedure 
 
- To 10 gm of sample add fluid soybean casein digest medium to make 100 ml, mix and 
incubate. 
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- Examine the medium for growth. 
- If growth is present, use an inoculating loop to streak a portion of the medium on the 
surface of Baird Parker agar medium.  
- Cover, invert, and incubate dishes at 35-37 c for 48 hours.  
- If upon examination, non-of the plates contains colonies, the tested sample meets the 
requirements for freedom from Staphylococcus aureus. 
 
c- Pseudomonas aeruginosa 
 
Procedure 
-To 10 gm cream add fluid soybean casein digest medium to make 100 ml, mix, and 
incubate.  
-Examine the medium for growth, if growth is present, use an inoculating loop to streak 
a portion of the medium on the surface of cetrimide agar medium in a petridish. 
-Cover, Invert and incubate the dish at 35-37 c for 48 hours  
-If upon examination, none of the plates contains greenish colonies, the test sample 
meets the requirements for freedom from Pseudomonas aeruginosa.   
 
2-2- Raw material analysis – (Terbinafine HCl)  
 
2-2-1- Identification Test 
 
a) It has two maximal UV absorbance at 283 nm and 223 nm in 0.1 M methanolic HCl 
for a solution of 2.0% mg/ml. 
 
b) The retention times of the sample and standard peaks should be identical for the 
chromatogram of assay 1. 
 
2-2-2- Organoleptic properties 
 
-The color of the powder should be white to off white crystalline powder. 
 
-The odor of the powder is odorless.  
 
2-2-3- Purity Test 
 
Check visually the powder to detect any strange material between the granules.    
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Limit  
No strange matter should be found. 
 
2-2-4- Moisture content 
 
-Method: Karl Fisher method. 
-Instrument: Karl Fisher apparatus 
-Limit: Maximum 1.0%. 
 
2-2-5-Melting Point 
 
Limit:  169 – 172 °c 
 
2-2-6- Assay 
 
Assay 1 
 
Reference: New developed method. 
 
Method: HPLC. 
 
Mobile Phase 
95.0% Methanol 5.0%, 0.1M ammonium acetate. 
  
To prepare 0.1M ammonium acetate, dissolve 0.77 g ammonium acetate in 100 ml 
water. 
 
Stationary Phase: RP18, 125*4 mm, 5m. 
 
UV-Wavelength (): 223 nm 
 
Flow rate: 1.0 ml/min.  
 
Temperature: Room temperature  
 
Vial volume: 20 l.  
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Standard/Sample  Preparation 
 
Dissolve 100.0 mg of  Terbinafine HCl (st/sa)in about 60 ml methanol. Complete the 
volume to 100.0 c by the same solvent. Dilute 1.25 ml in 50.0 ml using mobile phase. 
 
Procedure 
  
Prepare the vials for the sample solution. Carry out the automatic procedure for the 
pump, injection, detection, presentation, and calculation. Measure the percent of the 
peaks other than the principal peak 
   
Calculation 
 
% Terbinafine  = (Sample peak area /Standard peak area) * 100  
 
Assay 2 
 
Reference: Home method 
 
Method: UV absorbance at 223 nm. 
 
Procedure:  
 
Dissolve 100 mg of Terbinafine HCl in a 100 ml volumetric flask using about 60 ml of 
0.1M methanolic HCl, dilute to the mark using the same solvent. Transfer 2 ml into a 
100 ml volumetric flask containing about 60 ml of 0.1M methanolic HCl, dilute to the 
mark using the same solvent. Read the UV absorbance at 223 nm. Compare the result 
with a standard solution has the same concentration and solvent. 
 
Calculation 
 
% Terbinafine  = (Sample absorbance /Standard absorbance) * 100  
 
Limit: 98.0% -102.0% 
 
Assay 3 
 
Reference: Home method. 
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Method: Titration with 0.1 N NaOH 
 
Procedure 
 
Dissolve about 500 mg of Terbinafine HCl in 80 ml of methanol, add 10 ml of water 
and titrate with 0.1N NaOH using phenol red solution as indicator. Each ml of 0.1N 
NaOH is equivalent to 32.79 mg of substance. 
 
% Terbinafine  = (Sample titrant volume * 32.79/sample wt) * 100  
 
Limit: 98.0% - 102.0% 
 
2-2-7- Degradation 
 
Procedure Follow the same procedure mentioned in assay 1.  
 
Calculation % Impurity  = (Sample Peak area/Principal Peak Area ) * 100  
 
Limit Total of impurities areas < 1.0 % of the principal peak area.  
 
2- 3- Manufacturing Trials  
 
To create a new formula, many trials should be carried out. Many ideas can be tried 
using small trials of about 250 g cream. The best formula can be expanded to be one 
kilogram or more. The selected formulas are kept under accelerated stability study to 
check the chemical, physical, and microbial properties.  
 
Materials 
 
GMS (SE) Obtained from Cognis (Deutschland GmbH . D-40551 Dusseldorf), B.No. 
CA11510003) 
Eumulgin B2 Obtained from Cognis (Deutschland GmbH . D-40551 Dusseldorf), B.No. 
CD20240003 
Propyl Paraben Obtained from Clarient, (south wales Site, Mid Glamorgan CF38 2SN), 
B.No. 14917 
Methyl Paraben Obtained from Clarient, (south wales Site, Mid Glamorgan CF38 2SN), 
B.No. GBGA003033  
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Chloro-cresole Obtained from Merck Schuchardt OHG, (D-85662 Hohenbrunn,) B.No. 
S34094 
Cetostearyl alcohol Obtained from Ellis & Everard  , B.No. 70-04072000 
Liquid paraffin obtained from Compton B.V-Wezerstrast, B.No 450402 
Phenoxy-ethanol, obtained from Merck, Germany. 
Purified water obtained from Milli Q apparatus 
Terbinafine HCl obtained from Cross chem. International Company, Switzerland, B.No 
20041103 
Vaseline White Obtained from Honeywell, (Eupen, Belgium), B.No. 21045 
TEA Obtained from Merck, Germany , (Israel), B.No. 022005367 
Ethanol absolute Obtained from Hayman, (Eastways Park Witham, England), B.No. 
02/155C6 
 
Equipment and Tools 
  
Beakers 500 ml 
Balance,  (sensitivity, 0.01 g) Precisa, XT 220A 
Erweka mixer (14L): Erweka co., AR401 , Germany 
Water bath: Julabo co., SW22. 
In addition to all Analysis equipment mentioned above (See 2-1). 
 
2-3-1- O/W Method 
 
General Manufacturing procedure 
 
-Melt the hydrophobic materials by using water bath at temperature of 75 ºc. 
-At the same time, heat the water at the same temperature by using the water bath.  
- Add the hydrophilic materials to the water phase while mixing. 
- Add gradually while mixing, the oil phase to the water phase, both at 75 ºc by using 
the mixer. 
- Continue the mixing and cool the cream to 50 ºc. 
- Dissolve the active principle (Terbinafine HCl) by ethanol.   
- When the cream reaches the temperature of 50 ºc, add the active principle solution to 
the cream while mixing. Adjust the pH to 4.6 + 0.2 by drops of tri-ethanol amine.        
-Continue the mixing and cool the cream to room temperature. 
- Carry out all the important tests that employ the trial aim. 
- Select the best trial that contains materials of low cost, available, pure, less toxicity, do 
not effect on analysis and that are used easily. The trial that complies with all 
requirements of the cream, such as good penetration, absence of tackiness, lower 
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greasiness, smoothness of cream on the skin, good viscosity, good  pH, stable 
(physically and chemically), lower irritation,  and good organoleptic properties.    
 
2-3-1-1-Selection of Ingredients 
 
1- Selection of Emulsifying Agents  (Trials  1- 8) 
See tables from [2-1] to [2-8] 
 
a- Selected material: GMS (SE)  
 
-Trial No. 1, (T1) 
 
Table [2-1] Formulation of Terbinafine cream using GMS (SE) as emulsifier 
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
GMS (SE) Emulsifying agent 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
Vaseline white Base 10.0 
TEA Alkalizing agent 1.0 
Water  Continuous phase 191.5 
Total   250.0 
 
b- Selected material: Eumulgin B2 (Cetearth 20) 
 
Trial No. 2, (T2) 
 
Table [2-2] Formulation of Terbinafine cream using Eumulgin B2 as emulsifier 
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.50 
Eumulgin B2 Emulsifying agent 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
Vaseline white Base 10.0 
TEA Alkalizing agent 1.0 
Water  Continuous phase 191.5 
Total   250.0 
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c- Selected material: Cetostearyl Alcohol 
 
Trial No. 3, (T3) 
                         
Table [2-3] Formulation of Terbinafine cream using cetostearyl alcohol as emulsifier  
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
Cetostearyl Alcohol Emulsifying agent  20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
Vaseline white Base 10.0 
TEA Alkalizing agent 1.0 
Water  Continuous phase 191.5 
Total   250.0 
 
d- Selected materials: Cetostearyl Alcohol and GMS (SE) 
 
Trial No. 4, (T4) 
 
Table [2-4] Formulation of Terbinafine cream using Cetostearyl Alcohol and GMS (SE) as emulsifiers  
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
Cetostearyl Alcohol Emulsifying agent (aux) 20.0 
GMS (SE) Emulsifying agent 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
Vaseline white Base 10.0 
TEA Alkalizing agent 1.0 
Water  Continuous phase 171.5 
Total   250.0 
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e Cetostearyl Alcohol and Eumulgin B2 
 
Trial No. 5, (T5) 
 
Table [2-5] Formulation of Terbinafine cream using Cetostearyl Alcohol and Eumulgin B2 as 
emulsifiers  
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
Cetostearyl Alcohol Emulsifying agent (aux) 20.0 
Eumulgin B2 Emulsifying agent 20.0 
Liquid paraffin Emollient  20.0 
TEA Alkalizing agent, Enhancer 1.0 
Ethanol 96% Solvent, Enhancer 5.0 
Vaseline white Base  10.0 
Water  Continuous phase 171.5 
Total   250.0 
 
f- GMS (SE) and Eumulgin B2 
 
Trial No. 6, (T6) 
 
Table [2-6] Formulation of Terbinafine cream using GMS (SE) and Eumulgin B2 as emulsifiers  
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
GMS (SE) Emulsifying agent  20.0 
Eumulgin B2 Emulsifying agent 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
TEA Alkalizing agent 1.0 
Vaseline white Base 10.0 
Water  Continuous phase 171.5 
Total   250.0 
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g- Selected materials (Cetostearyl Alcohol, GMS (SE) and Eumulgin B2) 
 
Trial No. 7, (T7) 
 
Table [2-7] Formulation of Terbinafine cream using Cetostearyl Alcohol, GMS (SE) and Eumulgin B2 
as emulsifiers  
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
Cetostearyl Alcohol Emulsifying agent (aux) 20.0 
Eumulgin B2 Emulsifying agent 20.0 
GMS (SE) Emulsifying agent 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
TEA Base 1.0 
Vaseline white Alkalizing agent 10.0 
Water  Continuous phase 151.5 
Total   250.0 
 
h- Selected materials: Cetostearyl Alcohol, GMS (SE) and Eumulgin B2 
 
Trial No. 8, (T8) 
                         
Table [2-8] Formulation of Terbinafine cream using Cetostearyl Alcohol, GMS (SE) and Eumulgin B2 
as emulsifiers (change qty) 
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
GMS (SE) Emulsifying agent  20.0 
Eumulgin B2 Emulsifying agent 10.0 
Cetostearyl alcohol Emulsifying agent (aux) 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
TEA Alkalizing agent 1.0 
Vaseline white Base 10.0 
Water  Continuous phase 161.5 
Total   250.0 
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- Selection of Preservative, Trials 9 – 11 
 
See tables from [2-9] to [2-11] 
 
For topical preparation, the preservative should be sensitive to the pseudomonas 
aeruginosa and staphylococcus aurous.  
 
There are many available preservatives such as phenoxy ethanol, chloro-m-cresol, 
methyl paraben, propyl paraben and others. 
 
1- Selected Preservative: phenoxy-ethanol 
 
Trial No. 9, (T9) 
 
Table [2-9] Selection of phenoxy ethanol as preservative for Terbinafine cream 
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
GMS (SE) Emulsifying agent  20.0 
Eumulgin B2 Emulsifying agent 10.0 
Cetostearyl alcohol Emulsifying agent (aux) 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
TEA Alkalizing agent 1.0 
Vaseline white Base 10.0 
Phenoxy - Ethanol Preservative 2.5 
Water  Continuous phase 159.0 
Total   250.0 
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2-Selected Preservative: Chloro-m-cresol 
 
Trial No. 10, (T10) 
 
Table [2-10] Selection of chloro-m-cresol as preservative for Terbinafine cream 
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
GMS (SE) Emulsifying agent  20.0 
Eumulgin B2 Emulsifying agent 10.0 
Cetostearyl alcohol Emulsifying agent (aux) 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
TEA Alkalizing agent 1.0 
Vaseline white Base 10.0 
Chloro–m-Cresol Preservative 2.5 
Water  Continuous phase 159.0 
Total   250.0 
 
3- Selected Preservatives MP & PP 
 
Table # [2-11] 
Trial No. 11 T11 
                     
Table [2-11] Selection of MP & PP as preservatives for Terbinafine cream 
Material Function  Material Qty (g) 
Terbinafine HCl Active material 2.5 
GMS (SE) Emulsifying agent  20.0 
Eumulgin B2 Emulsifying agent 10.0 
Cetostearyl alcohol Emulsifying agent (aux) 20.0 
Liquid paraffin Emollient  20.0 
Ethanol 96% Solvent 5.0 
TEA Alkalizing agent 1.0 
Vaseline white Base 10.0 
Methyl paraben Preservative 2.5 
Propyl paraben Preservative  0.5 
Water  Continuous phase 158.5 
Total   250.0 
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2-3-1-2- Selection of Procedure 
 
-Change Speed of Mixing 
 
Select the best formula from the trials (1-11) to start the following trials: 
 
Trial No. 12, (T12) mixing speed 20 rpm 
Trial No. 13, (T13) mixing speed 80 rpm 
Trial No. 14, (T14) mixing speed 120 rpm 
Trial No. 15, (T15) mixing speed 180 rpm 
  
-Change Temperature of Active material Addition 
 
Select the best formula from the last four trials to continue the trials. 
 
Trial No. 16, (T16) addition at 70 ºc   
Trial No. 17, (T17) addition at 60 ºc 
Trial No. 18, (T18) addition at 50 ºc 
 
2-4-Analytical Validation 
 
2-4-1- Trial Preparation 
 
Carry out the tests on the best-selected trial as mentioned in the trial preparation. 
 
2-4-2- Method: Use the HPLC assay method mentioned above (see 2.1.3.1) 
 
2-4-3- Reference: New developed method.  
 
2-4-4-Parameters to be tested 
 
1-Selectivity, 2-accuracy, 3-precision, 4-ruggedness, and 5-linearity. 
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2-4-4-1-Selectivity 
 
Analyze the following solutions under the same conditions in order to determine that 
there is no interference between the active material peak and the other peaks 
 
Standard Solution Preparation 
 
Dissolve 250.0 mg of Terbinafine HCl in about 60 ml mobile phase. Complete the 
volume to 100.0 ml. Dilute 1 ml into 100.0 ml using mobile phase. 
The final dilution concentration is 2.5% (mg/ml). 
 
Sample Solution Preparation 
 
Shake 0.25 gm of sample with about 60 ml of mobile phase for 20 min.. Filter through 
Whatman filter paper No. 4. Wash the filter paper by  about 30 ml mobile phase. Add 
the washings to the filtrate. Complete the volume to 100.0 ml using the same solvent. 
Filter the sample through a 0.22 m Millipore filter paper. 
 
Placebo Solution Preparation 
 
Shake 0.25 gm of placebo cream with about 60 ml of mobile phase for 20 min.. Filter 
through Whatman filter paper No. 4. Wash the filter paper by about 30 ml mobile 
phase. Add the washings to the filtrate. Complete the volume to 100.0 ml using the 
same solvent. Filter the sample through a 0.22 m Millipore filter paper. 
 
2-4-4-2-Accuracy and Precision 
 
Evaluate the accuracy and the precision of the method on three batches. Five samples 
are prepared from each batch. Each sample is injected three times. 
  
 Sample and standard solutions preparation Prepare the sample and the standard 
solutions as directed under Selectivity mentioned above. 
 
2-4-4-3-Ruggedness 
 
Prepare a sample and a standard solution as directed under Selectivity, and analyze 
according to the following criteria 
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1- Different elapsed assay times 
 
Analyze the same sample solution after 15 minutes, and after 3 hours of sample 
preparing. The samples are kept at room temperature. Inject each sample two times for 
three batches. 
 
2- Different sample temperature 
 
Analyze the same sample solution at temperature of 20 c and another at 40 c. Inject 
each sample two times for three batches. 
 
3- Different columns 
 
Analyze the same sample using three different columns but the same type. Inject each 
sample two times for three batches. 
 
2-4-4-4-Linearity 
 
Samples  Preparation 
 
-Preparation of stock solution 
 
Shake 3.75 gm of sample with about 60 ml of methanol for 20 min.. Filter through 
Whatman filter paper No. 4. Wash the filter paper by about 30 ml methanol. Add the 
washings to the filtrate. Complete the volume to 100.0 ml using the same solvent. Filter 
the sample through a 0.22 m Millipore filter paper. 
 
Preparation of 3.75% solution 
Dilute 5 ml of stock solution to 50 ml using methanol as a diluent. 
 
Preparation of 2.5% solution 
Dilute 3.33 ml of stock solution to 50 ml using ethanol as a diluent. 
 
Preparation of 3.125% solution 
Mix well 10.0 ml of 3.75.0% solution with 10.0 ml of 2.5% solution. 
 
Preparation of 1.875% solution 
Mix well 10.0 ml of 3.75% solution with 10.0 ml of methanol. 
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Preparation of 1.25% solution 
Mix well 10.0 ml of 2.5.0% solution with 10.0 ml of methanol. 
 
Procedure 
 
Follow HPLC assay method mentioned above (see 2-1). 
 
Inject each Sample preparation three times for three batches. 
 
2-4-5-Acceptance Criteria 
 
Parameter Statistical measure Limit 
 
Selectivity 
 
             Resolution (R) 
 
Percent of Recovery (placebo) 
No interference between the 
active material peak and 
other peaks (R > 1.5)  
 
Zero  
Accuracy Percent of Recovery 98.00 - 102.00 
Precision Coefficient of Variation Maximum  1.50 
Ruggedness Coefficient of Variation.  Maximum  1.50 
Linearity and 
Range 
Correlation Coefficient 
 
Minimum 0.99980  
 
 
2-4-6-Validation Report 
 
At final, a validation report should be prepared. The report should contain the, data, 
results, conclusion, and recommendation.   
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2-5-Stability Study 
 
2-5-1-Kind of Study:  Accelerated. 
  
2-5-2- Trial Preparation 
 
Carry out the tests on the best selected trial as mentioned in the trial preparation. 
 
2-5-3-Analysis Methods   
 
Use the HPLC assay method mentioned above (see 2-1).  
 
2-5-4-Reference: New developed method. 
2-5-5-Qty of samples 
 
Keep 8 tubes of 15 gm for each batch. Keep three batches. (Total = 24 tubes) 
 
2-5-6-Tests to be monitored 
 
Assay, pH, color, odor, degradation, tackiness, greasiness, viscosity, skin allergies, 
microbial contamination, contamination, and physical stability.   
     
2-5-7-Procedure 
 
The samples of three batches are stored under condition (40 c, 75%  RH) for six 
months in cooled incubator. They should be analyzing at zero time, 30 days, 60 days, 90 
days and at 180 days. This will lead to one of the following  
 
If a significant change occurs under the mentioned condition, the master formula must 
be modified.  
 
Fill the results of analysis for each batch in the format mentioned in table [2-14] 
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Table [2-14] results of analysis format for stability study with tests limits 
Test Limit 
Physical stability Separation is prohibited after centrifusion 
Tackiness Tackiness is prohibited after application 
Greasiness Greasiness is prohibited after application 
Viscosity 11250 - 13500 cp 
Appearance of applied film Transparent after application 
Skin allergies (irritation) Irritation is prohibited 
Assay  90.0 – 110.0 % 
Identification (active) HPLC Rt is identical to standard 
Cream properties Homogeneous, white, and smooth cream, free from 
air bubbles. The smell should be acceptable 
pH 4.4 - 4.8 
Grittiness Smooth  cream after application 
Microbial contamination 
       Cfu/gm 
 
Total count < 1000 
Pseudomonas a. = 0 
Staphylococcus. a. = 0 
 
2-5-8-Stability Report 
 
At final, a stability study report should be prepared. The report should contain the data, 
results, and conclusion. 
 
2-6- Penetration Test 
 
The penetration test should be performed using Franz Diffusion Cell. 
 
2-6-1- materials and tools 
 
Phosphate buffer 7.4  , octanol (Merck), methanol (Merck, HPLC grade), ammonium 
acetate (Merck), Lamisil cream, thesis cream, Franz Diffusion Cell, HPLC 
(Merck,hitachi), (dialysis membrane 32/32, size 8, MW CO- 12000-14000 Daltons), 
organic solvent resistant millipore filter (45 mm* 0.22 m). 
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2-6-2- Procedure 
 
-Preparation of dialysis membrane 32/32 
 
Soak 2 pieces of 3.0 x 3.0 cm membrane in a 200 ml beaker containing about 100 ml 
distilled water for 24 hours. 
 
- Preparation of organic millipore filter (0.22 m) 
 
Soak 2 pieces of 45 mm organic millipore filter (0.22 m) in a 200 ml beaker containing 
about 50 ml octanol for 24 hours. 
 
-Franz Diffusion Cell Set up 
 
The cell is set up at constant temperature of 32 c by circulating water at 32 c through 
an external water jacket. A layer of dialysis membrane is put on the surface of the 
receptor compartment followed by the millipore filter. Another dialysis membrane is put 
over the filter. A sample of about 0.5 g is transferd from each cream to the surface of the 
dialysis membrane with good distribution. The donor compartment must coverd with 
parafilm. The receptor compartment must filled with phosphate buffer pH 7.4 and 
stirred by means of spinning bar magnet. Receptor solution samples, 2.0 ml aliquates,  
must withdrawn through sampling port of the receptor compartment at varoius time 
intervals. The cells must refilled with receptor solution to substitute the sampled 
quantity. The experiments should run for 6 hours.  
 
- Samples analysis 
  
Take a sample every 60 minutes from each tested cream (thesis sample & Lamisil 
sample). 
 
Use the HPLC analysis method described above (see 2-1) to determine the dissolved 
quantity at each stage. 
 
 Plot the data obtained to get the penetration curves for both formulas. 
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2-7- Phase Diagram Preparation 
 
2-7-1- Materials 
 
Tween 80 obtained from Eignmann & Veronelli S.P.A, B.No 1040210114. 
Terbinafine HCl obtained from cross chem. International company, Switzerland, B.No 
20041103 
Water (purified) obtained from Milli Q apparatus,  
 
2-7-2- Equipment & Tools 
 
Water bath Julabo SW22 
Vortex, Gennie vortex, scientific industries, USA.    
Analytical balance Precisa XT 220A 
Test tubes, 5 ml 
 
 
2-7-3- Procedure 
 
2-7-3-1-Preparation of different concentrations of water and tween 80 mixtures 
 
Prepare the quantity described in table [2-15] in a suitable container of about 15 gm. 
Mix well manually and by vortex. The samples are kept in water bath for 24 hours at 
room temperature. 
 
 
2-7-3-2- Phase Diagram Preparation 
 
Prepare the mixtures using the quantity described in table [2-16] in test tubes of 5 ml. 
Mix well manually, and by vortex. The samples are sonicated for one hour and kept in 
water bath for 24 hours at room temperature, and then the tubes are centrifuged at 5000 
r/m for 15 min.  
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Table [2-15] Preparation of Water-Tween 80 mixtures 
Set # Water% Tween 80% Wt Water Wt Tween 80 
1 100.0 0.0 15.000 0.000 
2 95.0 5.0 14.250 0.750 
3 90.0 10.0 13.500 1.500 
4 85.0 15.0 12.750 2.250 
5 80.0 20.0 12.000 3.000 
6 75.0 25.0 11.250 3.750 
7 70.0 30.0 10.500 4.500 
8 65.0 35.0 9.750 5.250 
9 60.0 40.0 9.000 6.000 
10 55.0 45.0 8.250 6.750 
11 50.0 50.0 7.500 7.500 
12 45.0 55.0 6.750 8.250 
13 40.0 60.0 6.000 9.000 
14 35.0 65.0 5.250 9.750 
15 30.0 70.0 4.500 10.500 
16 25.0 75.0 3.750 11.250 
17 20.0 80.0 3.000 12.000 
18 15.0 85.0 2.250 12.750 
19 10.0 90.0 1.500 13.500 
20 5.0 95.0 0.750 14.250 
21 0.0 100.0 0 15.000 
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Table [2-16] Qty of Terbinafine needed to be added to Tween 80, and Water mixtures   
Terbinafine% *Mixture% Wt Terbinafine (gm) Wt Mixture 
100 0.0 2.500 0 
90 10.0 2.250 0.250 
80 20.0 2.000 0.500 
70 30.0 1.750 0.750 
60 40.0 1.500 1.000 
50 50.0 1.250 1.250 
40 60.0 1.000 1.500 
30 70.0 0.750 1.750 
20 80.0 0.500 2.000 
10 90.0 0.250 2.250 
5 95.0 0.125 2.375 
4 96.0 0.100 2.400 
3 97.0 0.075 2.425 
2 98.0 0.050 2.450 
1 99.0 0.025 2.475 
0 100.0 0 2.500 
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3- DATA, CALCULATIONS & RESULTS 
 
3-1- Analysis Results of Raw material (Terbinafine HCl) 
 
3-1-1-Data 
 
The data are summarized in Table [3-1] 
 
Table [3-1]-Data for Terbinafine HCl analysis as raw material 
TEST DATA 
Identification 
        UV 
        HPLC 
 
Two Maxima peaks at 283 nm &223 nm   
The retention time of sa and standard are identical 
Melting Point 171 °c, 
Solubility Soluble in methanol,methylene chloride, ethanol, and 
slightly soluble in water 
Color A white to off-white crystaline powder 
Odor Odorless 
Moisure content (KF) 0.24% 
Assay (UV) St: 1.694 AU, sa: 1.690 AU 
Assay (titration) Wt (sa) 500.0 mg, Volume of NaOH: 15.2 ml 
Assay (HPLC) Area (sa): 4556408 & 4523377,  
Area (st): 4484335, 4504211 
 
3-1-2-Calculation 
 
% Terbinafine (UV) = 1.690/1.694 *100 = 99.80 
 
% Terbinafine (Tit.) = 15.1*32.7/500 *100 = 99.41 
 
%Terbinafine (HPLC) 
 
   [(4556408+4523377)/2]/[ (4484335+4504211)]/2  *100= 101.06 
 
3-1-3-Results (RM) 
 
See Table [3-2] 
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Table [3-2]-Result  of Terbinafine HCl analysis as raw material 
TEST RESULT LIMIT 
Identification 
        UV 
 
         HPLC 
 
Conform 
 
The retention times of 
sample and standard 
are identical 
 
Two Maxima peaks at 283 
nm &223 nm 
The retention times of sample 
and standard are identical 
Melting Point 171 c° 169 - 172 c° 
Solubility Soluble in methanol Soluble in methanol 
Color A white to offwhite 
crystaline powder 
A white to offwhite crystaline 
powder 
Odor Odorless odorless 
Moisure content (KF) 0.24% Max. 1.0% 
Assay (UV) 99.76 98.0*102.0% 
Assay (titration) 99.41% 98.0-102.0% 
Degradation (HPLC) Absent Max 1.0% 
  
 
Figure [3-1] and [3-2] UV spectrum for terbinafine HCl  as raw material (standard and sample 
respectively) 
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3-2- Data & Result for Lamisil Cream & Trials  
 
3-2-1- Data & Result for Lamisil Cream Assay 
 
B.No.: WB112 
 
See Table [3-3]  
 
Table [3-3]: Analytical data & results for Lamisil cream (brand) analysis by HPLC 
Sample  Peak Area 1 Peak Area 2 Average Result 
Standard 4504211 4484335 4494273 101.17% 
Lamisil  4547560 4546165 4546863 
 
 
3-2-2- Data & Results for Trials 1-10 analysis (Assay) 
 
Table [3-4]:Analytical data & results for trials 1-10 analyzed by HPLC 
Sample  Peak Area Result  (Sa/St ) 
Standard  5094234 - 
Trial 1 5113111 100.37 
Trial 2 5245922 102.98 
Trial 3 5130351 100.71 
Trial 4 5170592 101.50 
Trial 5 5133338 100.77 
Trial 6 5189892 101.88 
Trial 7 5162534 101.34 
Trial 8 5137193 100.84 
Trial 9 5172290 101.53 
Trial 10 5177681 101.64 
 
49 
 
3-2-3- Data & Results for Trials  11-18 analysis (Assay) 
 
Table [3-5]: Analytical data for the trials 11-18  analyzed by HPLC 
Sample  Peak Area Result  (Sa/St ) 
Standard 4381545 _ 
Trial 11 4434701 101.21 
Trial 12 4374760 99.85 
Trial 13 4405891 100.56 
Trial 14 4404382 100.52 
Trial 15 4364742 99.62 
Trial 16 4378750 99.94 
Trial 17 4385059 100.08 
Trial 18 4409452 100.64 
 
 
3-2-4- Data & Results for Content  Uniformity 
 
Trial # 12: Uniformity of Content Data 
 
Table [3-6]: Analytical data & results for trial # 12, analyzed by HPLC for content uniformity test 
St 
Sample 
A 
%Av. 
 Result sa A 
Sample  
B 
% Av Result 
sa B 
Sample  
C 
% Av Result 
sa C Limit 
4381545 4316891 99.09 
  
4399268 99.66 
  
4390239 99.87 
  
85.00%-115.00% 
  4433106 4399268 4366658 4394429 
 
 
Trial # 13: Uniformity of Content Data 
 
Table [3-7]: Analytical data & results for trial # 13  analyzed by HPLC for content uniformity test 
St 
Sample 
A 
% Av Result 
sa A 
Sample 
 B 
% Av Result 
sa B Sample C 
% Av Result 
sa C Limit 
4381545 4468538 101.42 
  
4440330 100.83 
  
4505771 101.96 
  
85.00%-115.00% 
  4433106 4452419 4428224 4462840 
 
Trial # 14: Uniformity of Content Data 
 
Table [3-8]: Analytical data & results for trial #14 analyzed by HPLC for content uniformity test 
St 
Sample 
A 
% Av Result 
sa A 
Sample 
 B 
% Av Result 
sa B Sample C 
% Av Result 
sa C Limit 
4381545 4450904 99.02 
  
4444512 101.32 
  
4462462 101.34 
  
85.00%-115.00% 
  4433106 4258412 4467407 4451291 
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Trial # 15: Uniformity of Content Data 
 
Table [3-9]: Analytical data & results for trial # 15 analyzed by HPLC for content uniformity test 
St 
Sample 
A 
% Av Result 
sa A 
Sample 
 B 
% Av Result 
sa B Sample C 
% Av Result 
sa C Limit 
4381545 4463765 101.51 
  
4367212 99.96 
  
4517198 102.67 
  
85.00%-115.00% 
  4433106 4464526 4425422 4513245 
 
 
Final Results (Content Uniformity) 
 
From the data mentioned above, the content uniformity test is pass for all trials (12 -15).   
 
 
Results for Lamisil analysis (All tests) 
 
 Table [3-10]: Analytical result for Lamisil cream (brand) 
TEST RESULTS 
Viscosity 12200 cps 
Organoleptic properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.65 
Greasiness No grease after application 
Allergies No irritation  
Microbial contamination cfu/g 
Total count 
 Pseudomonas a. 
       Staphylococcus a. 
 
 <23 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No grittiness after application 
Degradation  Absent  
Assay  101.17% 
Analysis consideration  No analytical problems 
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According to the result of analysis for Lamisil cream, our generic cream should 
 be comformable to the brand product especially for composition, pH (+ 0.2), 
 also for the viscosity (+ 10.%), and the other tests mentioned in the certificate. 
 
3-3- Trials Results 
 
3-3-1-Selection of Excipients 
 
Tests: Viscosity, Colour, Odour, Centrifusion (phase separation), pH,  Smoothness,  
Greasiness, Irritation, Microbial contamination, Degradation,  Tackiness and 
Assay. 
 
3-3-1-1-Selection of   Emulsifying Agents 
 
1-: Using of Glyceryl Mono Stearate GMS (SE) 
 
Trial # 1,  See Table [3-11] 
 
Table [3-11]: Analysis results for Terbinafine cream using GMS (SE) as an emulsifying agent 
TEST RESULTS 
Viscosity 6212 cps 
Organoleptic properties 
          Color 
          Odor  
          Appearance   
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles and impurities 
Phase stability (centrifusion) Slight separation  
pH 4.60 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
Total count 
 Pseudomonas a. 
       Staphylococcus a. 
 
Total count: 350 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  Untacky cream after application 
Degradation  Absent  
Assay  100.4% 
Analysis consideration  No analytical problems 
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2- Using of Eumulgin B2 
 
See Table [3-12] 
 
Trial # 2 
 
Table [3-12]: Analysis results for Terbinafine cream using Eumulgin B2 as an emulsifying agent 
TEST RESULTS 
Viscosity 5863 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) Slight separation  
pH 4.54 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
Total count 
 Pseudomonas a. 
       Staphylococcus a. 
 
Total count:  275 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No greatness after application 
Degradation  Absent  
Assay  100.7% 
Analysis consideration  No analytical problems 
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3-: Using of Cetostearyl Alcohol 
 
See Table [3-13] 
 
Trial # 3 
 
Table [3-13]: Analysis results for Terbinafine cream using cetostearyl alcohol as an emulsifying agent 
TEST RESULTS 
Viscosity 2902 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) Separation of small phase  
pH 4.75 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
Total count 
 Pseudomonas a. 
       Staphylococcus a. 
 
Total count:  325 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Degradation  Absent  
Assay  100.7% 
Analysis consideration  No analytical problems 
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4- Using of Cetostearyl Alcohol and GMS (SE) 
 
See Table [3-14] 
 
Trial # 4 
 
Table [3-14]: Analysis results for Terbinafine cream using GMS (SE) & cetostearyl alcohol as 
emulsifying agents 
TEST RESULTS 
Viscosity 7046 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No Separation   
pH 4.51 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
Total count 
 Pseudomonas a. 
       Staphylococcus a. 
 
Total count:  180 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Degradation  Absent  
Assay  101.5% 
Analysis consideration  No analytical problems 
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5-: Using of Cetostearyl Alcohol and Eumulgin B2 
 
See Table [3-15] 
 
Trial # 5 
 
Table [3-15]: Analysis results for Terbinafine cream using emulgin B2 & cetostearyl alcohol as 
emulsifying agents 
TEST RESULTS 
Viscosity 7810 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) Separation of small phase  
pH 4.70 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
 Total count 
 Pseudomonas a. 
 Staphylococcus a. 
 
Total count: 225 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Degradation  Absent  
Assay  100.7% 
Analysis consideration  No analytical problems 
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6-: Using of GMS (SE) and Eumulgin B2 
 
See Table [3-16] 
 
Trial # 6 
 
Table [3-16]: Analysis results for Terbinafine cream using GMS (SE) & Eumulgin B2 as emulsifying 
agents  
TEST RESULTS 
Viscosity 10734 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.58 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
    Total count 
    Pseudomonas a. 
    Staphylococcus a. 
 
Total count: 330 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Degradation  Absent  
Assay  101.9% 
Analysis consideration  No analytical problems 
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7- Using of Cetostearyl Alcohol, GMS (SE) and Eumulgin B2 
 
See Table [3-17] 
 
Trial # 7 
 
Table [3-17]: Analysis results for Terbinafine cream using GMS (SE), Eumulgin B2 & Cetostearyl 
alcohol as emulsifying agents 
TEST RESULTS 
Viscosity 14160 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.57 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
     Total count 
     Pseudomonas a. 
     Staphylococcus a. 
 
Total count: 385 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Degradation  Absent  
Assay  101.3% 
Analysis consideration  No analytical problems 
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8-: Using of Cetostearyl Alcohol, GMS (SE) and Eumulgin B2 (Change qty) 
 
See Table [3-18] 
 
Trial # 8 
 
Table [3-18]:Analysis results for Terbinafine cream using GMS (SE), Eumulgin B2 & Cetostearyl 
alcohol as emulsifying agents (different qty) 
TEST RESULTS 
Viscosity 12736 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Benzyl alcohol odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.65 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
    Total count 
    Pseudomonas a. 
    Staphylococcus a. 
 
Total count: 362 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  100.8% 
Analysis consideration  No analytical problems 
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 3-3-2- Selection of Preservative 
 
a- Using of Phenoxy - Ethanol 
 
See Table [3-19] 
 
Trial # 9 
 
Table [3-19]:Analysis results for Terbinafine cream using phenoxy ethanol, as a preservatve 
TEST RESULTS 
Viscosity 12912 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.71 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
    Total count 
    Pseudomonas a. 
    Staphylococcus a. 
 
Total count: 213 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  101.5% 
Analysis consideration  No analytical problems 
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b- Using of Chloro –M- Cresol 
 
See Table [3-20] 
 
Trial # 10 
 
Table [3-20]:Analysis results for Terbinafine cream using chloro-m-cresol as  a preservative 
TEST RESULTS 
Viscosity 13001 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.60 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g 
    Total count 
    Pseudomonas a. 
    Staphylococcus a. 
 
Total count: <23 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  101.6% 
Analysis consideration  No analytical problems 
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c- Using of MP & PP 
 
See Table   [3-21]  
 
Trial # 11 
 
Table[3-21]: Analysis results for Terbinafine cream using MP & PP as preservatives 
TEST RESULTS 
Viscosity 12759 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 Free from air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.69 
Greasiness No grease after application 
Skin allergies No irritation  
Microbial contamination cfu/g  
    Total count 
    Pseudomonas a. 
    Staphylococcus a. 
 
Total count: < 23 
3 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  101.2% 
Analysis consideration  Bad resolution 
 
62 
 
3-3-3- Selection mixing procedure 
3-3-3-1 Selection of Mixing Speed 
 
1-Mixing at 20 r/m 
See Table   [3-22]  
Trial # 12 
 
Table[3-22]: Analysis results for Terbinafine cream at mixing speed 20 rpm 
TEST RESULTS 
Viscosity 13111 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 No air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) Slight  separation 
pH 4.70 
Greasiness No grease after application 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  102.1% 
Uniformity of content Conform  
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2- Mixing at 80 r/m 
See Table   [3-23]  
Trial # 13 
 
Table [3-23]: Analysis results for Terbinafine cream at mixing speed 80 rpm 
TEST RESULTS 
Viscosity 12389 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 No air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No   separation 
pH 4.66 
Greasiness No grease after application 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  100.6% 
Uniformity of content Conform  
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3- Mixing at 120 r/m 
See Table   [3-24]  
Trial # 14 
 
Table [3-24]: Analysis results for Terbinafine cream at mixing speed 120 rpm 
TEST RESULTS 
Viscosity 12444 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
 
White homogeneous cream 
 Acceptable odor  
 No air bubbles 
 Free from dark impurities 
Phase stability (centrifusion) No   separation 
pH 4.66 
Greasiness No grease after application 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  100.5% 
Uniformity of content Conform  
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4- Mixing at 180 r/m 
See Table   [3-25]  
Trial # 15 
 
Table[3-25]: Analysis results for Terbinafine cream at mixing speed 180 rpm 
  TEST RESULTS 
Viscosity 11430 cps 
Organoleptic Properties 
          Color 
          Odor  
          Appearance   
 
White homogeneous cream 
 Acceptable odor  
 No air bubbles, Free from dark impurities 
Phase stability (centrifusion) No separation 
pH 4.60 
Greasiness No grease after application 
Microbial contamination cfu/g 
    Total count 
    Pseudomonas a. 
    Staphylococcus a. 
 
Total count: 23 
Absent 
Absent 
Tackiness  Untacky cream after application 
Grittiness  No Grittiness after application 
Assay  99.6% 
Uniformity of content Conform  
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3.3-3-2- Selection of Temperature for Active material Addition 
 
Trial 16, 17 & 18, See Table   [3-26]  
 
Table [3-26]:Analysis results for Terbinafine cream while it is added at different temperatures 
TRIAL NO. TEMP. ASSAY DEGRADATION  ASSAY 
T16 70 c 99.9% Absent 99.9% 
T17 60 c 100.1% Absent 100.1% 
T18 50 c 100.6% Absent 100.6% 
 
3-3-4-Summary For Trials Results  
 
A summary for all trials is described in Table [3-27] that shows the aim, test, result and 
accepting of refusing the trial.  
 
Table [3-27]: Summary for all trials including the tests, results and reason for accepting or refusing the trial 
T # Aim Test Status of formula  Results 
T1 GMS (SE) as emulsifier Centrifusion Fail, No Stability  Slight separation 
T2 Eumulgin B2 as emulsifier Centrifusion Fail, No Stability  Slight separation 
T3 Cetostearyl alcohol as emulsifier Centrifusion Fail, No Stability  Small separation 
T4 Cetostearyl alcohol & GMS (SE) 
as emulsifiers 
Viscosity  Fail, Lower than 
Lamisil [ by > 10%] 
7046 
T5 Cetostearyl alcohol & Emulgin 
B2 as emulsifiers 
Centrifusion Fail, Lower than 
Lamisil [ by > 10%] 
7810 
T6 Eumulgin B2 & GMS (SE) as 
emulsifiers 
Centrifusion Fail, Lower than 
Lamisil [ by > 10%] 
11734 
T7 Cetostearyl alcohol & GMS (SE) 
& Eumulgin B2 as emulsifiers 
Centrifusion Fail, higher than 
Lamisil [ by > 10%] 
14160 
T8 Cetostearyl alcohol & GMS (SE) 
& Eumulgin B2 as emulsifiers 
(different qty) 
All tests Good formula 12736 
T9 Phenoxy ethanol as preservative Microbial 
contamination 
Fail, No good 
inhibition for Contam.  
Some 
contamination 
T12 Mixing speed at 20 r/m Centrifusion  Separation Fail, No Stability  
T13 Mixing speed at 80 r/m All tests No problem Good  
T14 Mixing speed at 120 r/m All tests No problem Good  
T15 Mixing speed at 180 r/m Appearance  Air bubbles Appearance fail 
T16 Addition active at 70 c Degradation No problem Good  
T17 Addition active at 60 c Degradation No problem Good  
T18 Addition active at 50 c Degradation No problem Good  
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3-4-Validation Result  
 
3-4-1-Selectivity  
 
3-4-1-1-Limit 
 
Resolution factor: > 1.5  , Recovery: 98.0-102.0 
Rt for st & sa should be identical 
so Placebo should have no peak at Terbinafine RT. 
  
3-4-1-2-Data, Calculation and Results  
 
From the data shown in figure [3-3]  
Resolution factor: 2(2.13-1.24)/0.24-0.12 = 5.0  
Rt (st): 2.13 min.,  
Rt (st): 2.13 min., so they are identical 
Assay: 101.0% 
 No overlapping, resolution factor >>1.5, Rt is identical, % Recovery: 101.0%,  So the  
method is selective. 
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Resolution factor: 2(2.13-1.24)/0.24-0.12=5.0 
          Standard 
Selectivity Result 
   Placebo (no peak near 2.13 min) 
   Sample 
 
Rt (st): 2.13 min., Rt (st): 2.13 min 
 
 
 
 
 
Figure [3-3] selectivity results 
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3-4-2-Accuracy and Precision 
 
3-4-2-1- Data & Calculation 
 
Sample Peak Area  
standard 1 4,615,110 
standard 2 4,623,446 
Average 4,619,278 
 
Batch 1 
 
Sample 
Peak Area 
V1 %Assay P. Area V2 Assay 
Peak Area 
V3 Assay 
sample 1 4,612,341 99.85% 4,623,574 100.093% 4,621,704 100.053% 
sample 2 4,641,575 100.48% 4,627,452 100.177% 4,620,650 100.030% 
sample 3 4,628,710 100.20% 4,629,748 100.227% 4,620,098 100.018% 
sample 4 4,634,868 100.34% 4,615,634 99.921% 4,632,729 100.291% 
sample 5 4,633,868 100.32% 4,615,638 99.921% 4,619,183 99.998% 
Average 4,630,272 100.24% 4,622,409 100.068% 4,622,873 100.078% 
Coeff. Of var. 0.2390 0.1420 0.1200 
Av. coef. of var. 0.1670 
 
Batch 2 
 
Sample 
Peak Area 
V1 Assay 
P. Area 
V2 Assay 
Peak Area 
V3 Assay 
sample 1 4,616,346 99.937% 4,617,100 99.953% 4,626,778 100.162% 
sample 2 4,621,628 100.05% 4,628,996 100.210% 4,630,868 100.251% 
sample 3 4,618,458 99.982% 4,620,738 100.032% 4,627,052 100.168% 
sample 4 4,636,725 100.38% 4,625,563 100.136% 4,629,589 100.223% 
sample 5 4,636,330 100.37% 4,626,913 100.165% 4,627,052 100.168% 
Average 4,625,897 100.14% 4,623,862 100.099% 4,628,268 100.195% 
Coeff. Of var. 0.2140 0.0010 0.0004 
Av. coef. of var. 0.0718 
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Batch 3 
 
Sample 
Peak Area 
V1 Assay 
P. Area 
V2 Assay 
Peak Area 
V3 Assay        
sample 1 4,635,631 1.00 4,603,234 99.653% 4,595,080 99.476%        
sample 2 4,634,600 100.33% 4,592,505 99.420% 4,629,714 100.226%        
sample 3 4,594,949 99.47% 4,610,414 99.808% 4,623,889 100.100%        
sample 4 4,634,029 100.32% 4,626,254 100.151% 4,619,517 100.005%        
sample 5 4,732,844 102.46% 4,616,448 99.939% 4,609,687 99.792%        
Average 4,646,411 100.59% 4,609,771 99.794% 4,615,577 99.920%        
Coeff. Of var. 1.1000 0.0028 0.0029        
Av. coef. of var. 0.37        
 
 
3-4-2-2-Results 
 
Accuracy 
 
Batch Batch 1 Batch 2 Batch 3 Limit 
%Recovery 100.1 100.1 100.1 98.0%-102.0 
Av.(% Recovery) 100.1 98.0%-102.0 
 
Precision 
 
Batch Batch 1 Batch 2 Batch 3 Limit 
Coeff. of var. 0.167 0.072 0.369 Max 1.5 
Av. coef. of var. 0.202 Max 1.5 
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3-4-3-Linearity 
 
Data and Results for Batch 1 
 
Conc. P. Area sa 1 P. Area sa 2 P. Area sa 3 Peak Area Av. 
50% 2227663 2192040 2199413 2206372 
75% 3282383 3290950 3287233 3286855 
100% 4341119 4338800 4342678 4340866 
125% 5369006 5369621 5362946 5367191 
150% 6525758 6501894 6518412 6515355 
Average    4343328 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Calculation 
 
1-Correlation coefficient (correl)= square root of  R² 
                               =  square root of 0.9997 = 0.99985 
 
2- %Y-intercept = (64007/4343328) * 100 = 1.49 
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Data and Results for Batch 2 
 
Conc. P. Area sa 1 P. Area sa 2 P. Area sa 3 Peak Area Av. 
50% 2129675 2137955 2131978 2133203 
75% 3194978 3177527 3176264 3182923 
100% 4239913 4213709 4246936 4233519 
125% 5267740 5259401 5260527 5262556 
150% 6345254 6358644 6334777 6346225 
Average    4231685 
 
y = 4E+06x + 29414
R
2
 = 0.9999
0
1000000
2000000
3000000
4000000
5000000
6000000
7000000
0% 50% 100% 150% 200%
 
 
Calculation 
1-Correlation coefficient (correl)= square root of  R² 
                              =  square root of 0.9999 = 099995 
2- %Y-intercept = (29414/4231685) * 100 = 0.7
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Data and Results for Batch 3 
 
 
Conc P. Area sa1 P. Area sa2 P. Area sa3 Peak Area Av. 
50% 2167579 2178168 2167576 2171108 
75% 3176905 3204378 3178163 3186482 
100% 4195588 4225100 4247268 4222652 
125% 5301964 5450066 5276885 5342972 
150% 6298426 6310853 6372922 6327400 
Average    4250123 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Calculation 
 
1-Correlation coefficient (correl)= square root of 0.9997 = 0.99980 
2- %Y-intercept = (62493/4250123) * 100 = 1.47 
 
Calculation 
 
Batch 1 Batch 2 Batch 3 Limit 
0.99985 0.99995 0.99985 Min. 0.99980  
1.49 0.70 1.47 Max. 2.00 
 
From the above results for correlation coefficient and y intercept, the method is linear. 
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3-4-4-Ruggedness 
 
3-4-4-1- Data & Calculation 
 
a-Sample preparation time 
 
1- Keeping sample prepared for 15 minutes 
 
Standard 
 
Sample Peak Area  
st 1 4480064 
st 2 4549655 
Average 4514860 
 
Batch 1 
 
Sample Peak Area Assay 
sa 1 4524730 100.22 
sa 2 4510014 99.89 
Average 4517372 100.06 
Coeff. of variation 0.2300 
 
Batch 2 
 
Sample Peak Area Assay 
sa 1 4478768 99.20 
sa 2 4502534 99.73 
Average 4490651 99.46 
Coeff. of variation 0.3700 
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Batch 3 
 
Sample Peak Area Assay 
sa 1 4495224 99.57 
sa 2 4473364 99.08 
Average 4484294 99.32 
Coeff. of variation 0.3400 
 
2- Keeping sample prepared for 180 minutes 
 
Batch 1 
Sample Peak Area Assay 
sa 1 4501286 99.70 
sa 2 4506154 99.81 
Average 4503720 99.75 
Coeff. of variation 0.0760 
 
Batch 2 
 
Sample Peak Area Assay 
sa 1 4496748 99.60 
sa 2 4491729 99.49 
Average 4494239 99.54 
Coeff. of variation 0.0790 
 
Batch 3 
 
Sample Peak Area Assay 
sa 1 4514123 99.98 
sa 2 4519068 100.09 
Average 4516596 100.04 
Coeff. of variation 0.0390 
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b- Sample Temperature 
 
1- Sample Temperature at 20 °c 
 
Batch 1 
 
Sample Peak Area Assay 
sa 1 4496286 99.59 
sa 2 4512942 99.96 
Average 4504614 99.77 
Coeff. Of variation 0.2600 
 
Batch 2 
 
Sample Peak Area Assay 
sa 1 4513344 99.97 
sa 2 4507508 99.84 
Average 4510426 99.90 
Coeff. of variation 0.0900 
 
 
Batch 3 
 
Sample Peak Area Assay 
sa 1 4542486 100.61 
sa 2 4524722 100.22 
Average 4533604 100.42 
Coeff. of variation 0.2800 
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2- Sample Temperature at 40 °c 
 
Batch 1 
 
Sample Peak Area Assay 
sa 1 4525102 100.23 
sa 2 4525015 100.22 
Average 4525059 100.23 
Coeff. Of variation 0.0010 
 
Batch 2 
 
Sample Peak Area Assay 
sa 1 4503700 99.75 
sa 2 4528192 100.30 
Average 4515946 100.02 
Coeff. of variation 0.3800 
 
Batch 3 
Sample Peak Area Assay 
sa 1 4517373 100.06 
sa 2 4507328 99.83 
Average 4512351 99.94 
Coeff. of variation 0.1600 
 
C- Using different columns 
 
1- Column A 
 
Batch 1 
Sample Peak Area Assay 
sa 1 4545279 100.67 
sa 2 4515068 100.00 
Average 4530174 100.34 
Coeff. of variation 0.4700 
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Batch 2 
Sample Peak Area Assay 
sa 1 4529186 100.32 
sa 2 4496736 99.60 
Average 4512961 99.96 
Coeff. of variation 0.5100 
 
Batch 3 
 
Sample Peak Area Assay 
sa 1 4482638 99.29 
sa 2 4524847 100.22 
Average 4503743 99.75 
Coeff. of variation 0.6600 
 
2- Column B 
 
Batch 1 
 
Sample Peak Area Assay 
sa 1 4512393 99.95 
sa 2 4498122 99.63 
Average 4505258 99.79 
Coeff. of variation 0.2200 
 
Batch 2 
 
Sample Peak Area Assay 
sa 1 4495395 99.57 
sa 2 4480992 99.30 
Average 4488194 99.44 
Coeff. of variation 0.1900 
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Batch 3 
 
Sample Peak Area Assay 
sa 1 4521899 100.16 
sa 2 4509748 99.89 
Average 4515824 100.02 
Coeff. of variation 0.1900 
 
3-Column C 
 
Batch 1 
 
Sample Peak Area Assay 
sa 1 4492732 99.51 
sa 2 4506516 99.82 
Average 4499624 99.66 
Coeff. of variation 0.2160 
 
Batch 2 
 
Sample Peak Area Assay 
sa 1 4495811 99.58 
sa 2 4486266 99.37 
Average 4491039 99.47 
Coeff. Of variation 0.1500 
 
Batch 3 
 
Sample Peak Area Assay 
sa 1 4482638 99.29 
sa 2 4524847 100.22 
Average 4503743 99.75 
Coeff. of variation 0.6610 
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3-4-4-2-Results 
 
Sample preparation time 15 minutes 
 
Batch # %Assay Limit 
Coeff. Of 
variation Limit 
Batch 1 100.06 98.00-102.00 0.230 Max 1.500 
Batch 2 99.46 98.00-102.00 0.370 Max 1.500 
Batch 3 99.32 98.00-102.00 0.340 Max 1.500 
Average  99.61 98.00-102.00 0.313 Max 1.500 
 
Sample preparation time 180 minutes 
 
Assay %Result Limit Coeff. of variation Limit 
Batch 1 99.75 98.00-102.00 0.076 Max 1.500 
Batch 2 99.54 98.00-102.00 0.079 Max 1.500 
Batch 3 100.04 98.00-102.00 0.039 Max 1.500 
Average  99.78 98.00-102.00 0.065 Max 1.500 
 
Sample T: 20 °c 
 
Assay %Result Limit Coeff. of variation Limit 
Batch 1 99.77 98.00-102.00 0.260 Max 1.500 
Batch 2 99.90 98.00-102.00 0.090 Max 1.500 
Batch 3 100.42 98.00-102.00 0.280 Max 1.500 
Average  100.03 98.00-102.00 0.210 Max 1.500 
 
Sample T: 40 °c 
 
Assay %Result Limit 
Coeff. Of 
variation Limit 
Batch 1 100.23 98.00-102.00 0.001 Max 1.500 
Batch 2 100.02 98.00-102.00 0.380 Max 1.500 
Batch 3 99.94 98.00-102.00 0.160 Max 1.500 
Average 100.06 98.00-102.00 0.180 Max 1.500 
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Using column A 
 
Assay %Result Limit 
Coeff. Of 
variation Limit 
Batch 1 100.34 98.00-102.00 0.470 Max 1.500 
Batch 2 99.96 98.00-102.00 0.510 Max 1.500 
Batch 3 99.75 98.00-102.00 0.660 Max 1.500 
Average  100.02 98.00-102.00 0.547 Max 1.500 
 
Using column B 
 
Assay %Result Limit Coeff. of variation Limit 
Batch 1 99.96 98.00-102.00 0.220 Max 1.500 
Batch 2 99.75 98.00-102.00 0.190 Max 1.500 
Batch 3 99.95 98.00-102.00 0.190 Max 1.500 
Average  99.89 98.00-102.00 0.200 Max 1.500 
 
Using column C 
 
Assay %Result Limit Coeff. of variation Limit 
Batch 1 99.75 98.00-102.00 0.216 Max 1.500 
Batch 2 99.95 98.00-102.00 0.150 Max 1.500 
Batch 3 99.57 98.00-102.00 0.661 Max 1.500 
Average  99.76 98.00-102.00 0.342 Max 1.500 
 
 
Final Results for Ruggedness 
 
From the data mentioned above, all cases (conditions) were pass, no effect for changing  
time of preparation between 15 min and 180 minutes, also elevation in the temperature 
of the prepared solution from 20 °c to 40 °c did not affect on the accuracy and precision. 
Replacing the column used by other two columns did not also affect on accuracy and 
precision. So the method is valid for all mentioned conditions. 
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3-5- STABILITY STUDY   
 
The study was carried out on three batches ( 1, 2 & 3) using formula and mixing method 
of trial # 18. Also using method of analysis mentioned above. To ensure that the assay 
method is stability indicator, analysis for Terbinafine samples stored under stress 
condition  was done. The stress conditions were; in solution of 4 N HCl, 2 N NaOH, 
7.5% H2O2 and  in hot water solution, all were kept for an hour before analysis, see 
figure [3-4]. 
 
Each batch was injected  two times. The study aim is to check the stability of the cream 
under accelerated stability study after 1,2,3 and 6 months of manufacturing date. 
 
3-5-1-Data (Assay) 
 
See table [3-28] 
 
Table [3-28] stability study HPLC peak areas data for three batches through 6 months 
Peak Area  (0-time)  (30-days)  (60-days)  (90-days)  (180-days) 
St (vial 1) 4351282 4371962 4403995 4260571 4205144 
St (vial 2) 4319170 4316433 4421488 4268531 4211010 
St (av.) 4335226 4344198 4412742 4264551 4208077 
batch 1(vial 1) 4378993 4439125 4511796 4349326 4232168 
batch 1(vial 2) 4382746 4371962 4521782 4274779 4203851 
batch 1(av.) 4380870 4405544 4516789 4312053 4218010 
batch 2 (vial 1) 4378390 4405544 4454690 4258817 4227573 
batch 2 (vial 2) 4369315 4452438 4456569 4240869 4213924 
batch 2 (av.) 4373853 4428991 4455630 4249843 4220749 
batch 3 (vial 1) 4367079 4460986 4450727 4357321 4158508 
batch 3 (vial 2) 4348370 4455884 4520069 4317960 4233381 
batch 3 (av.) 4357725 4458435 4485398 4337641 4195945 
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3-5-2- Accelerated Stability Study Results 
 
Batch (1) 
 
See table [3-29] 
 
Table [3-29] stability study results of analysis for batch # 1 after re-cooling to room temperature 
Test 
0-Time 30-Days 60-Days 90-Days 180-Days Limit 
- 
24/10/2002 23/11/2002 22/12/2002 24/1/2003 24/4/2003 
Assay 101.05% 101.41% 102.36% 101.11% 100.24% 90.00-110.00% 
pH     4.65 4.6 4.63 4.58 4.64 4.40-4.80 
Greasiness no grease no grease no grease no grease no grease no grease 
Tackiness no tackiness no tackiness no tackiness no tackiness no tackiness no tackiness 
Appearance white cream white cream white cream white cream white cream white cream 
Odor conform conform conform conform conform conform 
Degradation no degrades no degrades no degrades no degrades no degrades no degrades 
Viscosity  12367 12120 12209 12115 12015 11000-14000 cps 
Phase 
Stability no separation no separation no separation no separation no separation no separation 
Smoothness smooth cream smooth cream smooth cream smooth cream smooth cream smooth cream 
Microbial 
Cont. <23 c/g <23 c/g <23 c/g <23 c/g <23 c/g <23 c/g 
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2- Batch (2) 
See Table [3-30] 
 
Table [3-30] stability study results of analysis for batch # 2 after re-cooling to room temperature 
Test 
0-Time 30-Days 60-Days 90-Days 180-Days 
Limit 
24/10/2002 23/11/2002 22/12/2002 24/1/2003 24/4/2003 
Assay 100.89% 101.95% 100.97% 99.66% 100.30% 90.00-110.00% 
pH     4.69 4.67 4.67 4.62 4.63 4.40-4.80 
Grittiness no grease no grease no grease no grease no grease no grease 
Tackiness no tackiness no tackiness no tackiness no tackiness no tackiness no tackiness 
Appearance white cream white cream white cream white cream white cream white cream 
Odor conform conform conform conform conform conform 
Degradation no degrades no degrades no degrades no degrades no degrades no degrades 
Viscosity  12301 11912 11896 11972 12013 11000-14000 cps 
Phase Stability no separation no separation no separation no separation no separation no separation 
Smoothness smooth cream smooth cream smooth cream smooth cream smooth cream smooth cream 
Microbial 
Contamination. <23 c/g <23 c/g <23 c/g <23 c/g <23 c/g <23 c/g 
 
3- Batch (3) 
See Table [3-31] 
 
Table [3-31] stability study results of analysis for batch # 3 after re-cooling to room temperature 
Test 
0-Time 30-Days 60-Days 90-Days 180-Days 
Limit 
24/10/2002 23/11/2002 22/12/2002 24/1/2003 24/4/2003 
Assay 100.52% 102.63% 101.65% 101.71% 99.71% 90.00-110.00% 
pH     4.64 4.622 4.68 4.63 4.59 4.40-4.80 
Grittiness no grease no grease no grease no grease no grease no grease 
Tackiness no tackiness no tackiness no tackiness no tackiness no tackiness no tackiness 
Appearance white cream white cream white cream white cream white cream white cream 
Odor conform conform conform conform conform conform 
Degradation no degrades no degrades no degrades no degrades no degrades no degrades 
Viscosity 12910 11987 11885 12005 12112 11000-14000 cps 
Phase Stability no separation no separation no separation no separation no separation no separation 
Smoothness smooth cream smooth cream smooth cream smooth cream smooth cream smooth cream 
Microbial 
Cont. <23 c/g <23 c/g <23 c/g <23 c/g <23 c/g <23 c/g 
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Final Result  for Stability Study   
 
From the chromatograms shown in figure [3-4], there is a complete or partial 
destruction for Terbinafine HCl for all reagents react with. Therefore, the assay method 
is stability indicator. The selected formula (T18) is stable under accelerated stability 
study. 
 
The product can be given two years as expiration time. 
 
 
86 
 
 
 
 
Terbinafine + 7.5% H2O2 
Analysis of Terbinafine Stored Under Stress Conditions 
Figure [3-4]: HPLC Analysis results for Terbinafine stored under stress conditions  
Terbinafine + 2 N NaOH 
Terbinafine + heat 
Terbinafine + 4 N HCl 
Terbinafine Standard 
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3-6-Penetration Test 
 
3-6-1- Data 
The penetration of generic cream was compared with penetration of 
Lamisil cream using Franz  Diffusion Cell. Table [3-32] shows the 
penetration results for both creams. 
Table [3-32]: HPLC Data and qty (ng) per cm²  for penetration of  generic cream and Lamisil 
cream 
Time (min) 
Generic Cream  Time (min) Lamisil Cream 
Peak Area Qty (ng/cm²) 
  
Peak Area Qty (ng/cm²) 
0 0 0 0 0 0 
40 212048 7.709 60 206133 7.494 
90 461287 16.770 90 545482 19.831 
120 750474 27.284 150 825253 30.002 
180 944504 34.338 218 997152 36.252 
240 1038344 37.749 270 1122320 40.802 
300 1119629 40.704 330 1217767 44.272 
360 1216779 44.236 375 1217867 44.276 
 
3-6-2- Result 
 
Figure [3-5] shows the comparison plot between penetration of generic cream 
and Lamisil cream. From the figure, we can conclude that there is a 
correspondence between the two creams. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure [3-5]: Penetration of generic cream and Lamisil cream using Franz Diffusion Cell. 
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3-7- Phase Diagram data & Results 
3-7-1- DATA FOR PHASE DIAGRAM PREPARATION 
 
Set #1 ( 100% water) 
 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.0000 2.5000 0.0000 100.0000 0.0000 Single phase 
2.4760 0.0256 0.0000 2.4760 1.0339 98.9767 0.0000 Two phases 
2.4700 0.0542 0.0000 2.4700 2.1943 97.8528 0.0000 Two phases 
2.4290 0.0760 0.0000 2.4290 3.1289 96.9661 0.0000 Two phases 
2.4000 0.1023 0.0000 2.4000 4.2625 95.9118 0.0000 Two phases 
2.3810 0.1250 0.0000 2.3810 5.2499 95.0120 0.0000 Two phases 
 
Set #2 ( 95% water+ 05% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.1250 2.3750 0.0000 95.0000 5.0000 Micelles 
2.4770 0.0254 0.1239 2.3532 1.0036 94.0357 4.9492 Two phases 
2.4600 0.0540 0.1230 2.3370 2.1285 92.9594 4.8926 Two phases 
2.4270 0.0770 0.1214 2.3057 3.0435 92.0787 4.8462 Two phases 
2.4020 0.1030 0.1201 2.2819 4.0776 91.0938 4.7944 Two phases 
2.3790 0.1240 0.1190 2.2601 5.2123 90.2936 4.7523 Two phases 
 
Set #3 ( 90% Water+ 10% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.2500 2.2500 0.0000 90.0000 10.0000 Micelles 
2.4756 0.0256 0.2476 2.2280 1.0127 89.0788 9.8976 Micelles 
2.4643 0.0523 0.2464 2.2179 2.0583 88.1296 9.7922 Two phases 
2.4322 0.0766 0.2432 2.1890 3.0234 87.2521 9.6947 Two phases 
2.4010 0.1014 0.2401 2.1609 4.0128 86.3531 9.5948 Two phases 
2.3780 0.1259 0.2378 2.1402 5.2944 85.4747 9.4972 Two phases 
 
Set #4 ( 85% Water+ 15% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.3750 2.1250 0.0000 85.0000 15.0000 Micelles 
2.4740 0.0256 0.3711 2.1029 1.0131 84.1295 14.8464 Micelles 
2.4650 0.0530 0.3698 2.0953 2.0853 83.2109 14.6843 Two phases 
2.4276 0.0766 0.3641 2.0635 3.0268 82.4000 14.5412 Two phases 
2.4030 0.1031 0.3605 2.0426 4.0770 81.5031 14.3829 Two phases 
2.3785 0.1258 0.3568 2.0217 5.2890 80.7301 14.2465 Two phases 
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Set #5 ( 80% Water+ 20% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.5000 2.0000 0.0000 80.0000 20.0000 Micelles 
2.4758 0.0258 0.4952 1.9806 1.0207 79.1749 19.7937 Micelles 
2.4600 0.0520 0.4920 1.9680 2.0505 78.3439 19.5860 Micelles 
2.4270 0.0760 0.4854 1.9416 3.0063 77.5709 19.3927 Two phases 
2.4020 0.1010 0.4804 1.9216 3.9953 76.7719 19.1930 Two phases 
2.3790 0.1260 0.4758 1.9032 5.2963 75.9760 18.9940 Two phases 
 
Set #6 ( 75% Water+ 25% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.6250 1.8750 0.0000 75.0000 25.0000 Micelles 
2.4766 0.0256 0.6192 1.8575 1.0121 74.2327 24.7442 Micelles 
2.4668 0.0527 0.6167 1.8501 2.0724 73.4312 24.4771 Micelles 
2.4269 0.0762 0.6067 1.8202 3.0128 72.7168 24.2389 Two phases 
2.4024 0.1023 0.6006 1.8018 4.0467 71.9368 23.9789 Two phases 
2.3770 0.1256 0.5943 1.7828 5.2840 71.2359 23.7453 Two phases 
 
Set #7 ( 70% Water+ 30% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.7500 1.7500 0.0000 70.0000 30.0000 Micelles 
2.4746 0.0257 0.7424 1.7322 1.0171 69.2805 29.6916 Micelles 
2.4650 0.0522 0.7395 1.7255 2.0541 68.5484 29.3779 Micelles 
2.4276 0.0763 0.7283 1.6993 3.0165 67.8669 29.0858 Micelles 
2.4023 0.1018 0.7207 1.6816 4.0258 67.1543 28.7804 Two phases 
2.3792 0.1264 0.7138 1.6654 5.3127 66.4687 28.4866 Two phases 
 
Set #8 ( 65% Water+ 35% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 0.8750 1.6250 0.0000 65.0000 35.0000 Micelles 
2.4753 0.0255 0.8664 1.6089 1.0092 64.3372 34.6431 Micelles 
2.4624 0.0515 0.8618 1.6006 2.0290 63.6684 34.2830 Micelles 
2.4275 0.0758 0.8496 1.5779 2.9960 63.0318 33.9402 Two phases 
2.4026 0.1025 0.8409 1.5617 4.0538 62.3404 33.5679 Two phases 
2.3798 0.1259 0.8329 1.5469 5.2904 61.7340 33.2414 Two phases 
 
Set #9 ( 60% Water+ 40% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.0000 1.5000 0.0000 60.0000 40.0000 Micelles 
2.4759 0.0253 0.9904 1.4855 1.0000 59.3931 39.5954 Micelles 
2.4658 0.0540 0.9863 1.4795 2.1253 58.7142 39.1428 Micelles 
2.4275 0.0750 0.9710 1.4565 2.9668 58.2018 38.8012 Two phases 
2.4026 0.1005 0.9610 1.4416 3.9737 57.5910 38.3940 Two phases 
2.3791 0.1265 0.9516 1.4275 5.3171 56.9708 37.9805 Two phases 
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Set #10 (55% Water+ 45% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.1250 1.3750 0.0000 55.0000 45.0000 Micelles 
2.4740 0.0257 1.1133 1.3607 1.0172 54.4345 44.5373 Micelles 
2.4625 0.0526 1.1081 1.3544 2.0716 53.8497 44.0589 Micelles 
2.4265 0.0766 1.0919 1.3346 3.0298 53.3169 43.6229 Two phases 
2.4060 0.1017 1.0827 1.3233 4.0163 52.7695 43.1750 Two phases 
2.3783 0.1262 1.0702 1.3081 5.3063 52.2286 42.7325 Two phases 
 
Set #11 (52.5% Water+ 47.5% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.1875 1.3125 0.0000 52.5000 47.5000 Two phases 
2.4770 0.0258 1.1766 1.3004 1.0200 51.9588 47.0103 Two phases 
2.4620 0.0525 1.1695 1.2926 2.0679 51.4039 46.5083 Two phases 
2.4273 0.0768 1.1530 1.2743 3.0367 50.8898 46.0432 Two phases 
2.4080 0.1018 1.1438 1.2642 4.0163 50.3705 45.5734 Two phases 
2.3793 0.1267 1.1302 1.2491 5.0559 49.8457 45.0985 Two phases 
 
Set #12 (50% Water+ 50% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.2500 1.2500 0.0000 50.0000 50.0000 Two phases 
2.4770 0.0258 1.2385 1.2385 1.0200 49.4846 49.4846 Two phases 
2.4620 0.0525 1.2310 1.2310 2.0679 48.9561 48.9561 Two phases 
2.4273 0.0768 1.2137 1.2137 3.0367 48.4665 48.4665 Two phases 
2.4080 0.1018 1.2040 1.2040 4.0163 47.9719 47.9719 Two phases 
2.3793 0.1267 1.1897 1.1897 5.3251 47.4721 47.4721 Two phases 
 
Set #13 (47.5% Water+ 52.5% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.3125 1.1875 0.0000 47.5000 52.5000 
gel 
(hexagonal) 
2.4770 0.0258 1.3004 1.1766 1.0200 47.0103 51.9588 
gel 
(hexagonal) 
2.4620 0.0525 1.2926 1.1695 2.0679 46.5083 51.4039 
gel 
(hexagonal) 
2.4273 0.0768 1.2743 1.1530 3.0367 46.0432 50.8898 
gel 
(hexagonal) 
2.4080 0.1018 1.2642 1.1438 4.0163 45.5734 50.3705 Two phases 
2.3793 0.1267 1.2491 1.1302 5.3251 45.0985 49.8457 Two phases 
 
91 
 
Set #14 (45% Water+ 55% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.3750 1.1250 0.0000 45.0000 55.0000 
gel 
(hexagonal) 
2.4765 0.0254 1.3621 1.1144 1.0043 44.5431 54.4416 
gel 
(hexagonal) 
2.4625 0.0526 1.3544 1.1081 2.0714 44.0589 53.8497 
gel 
(hexagonal) 
2.4273 0.0768 1.3350 1.0923 3.0369 43.6199 53.3132 Two phases 
2.4027 0.1016 1.3215 1.0812 4.0180 43.1743 52.7686 Two phases 
2.3792 0.1259 1.3086 1.0706 5.2917 42.7384 52.2358 Two phases 
 
Set #15 (40% Water+ 60% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.5000 1.0000 0.0000 40.0000 60.0000 
gel 
(hexagonal) 
2.4760 0.0253 1.4856 0.9904 1.0006 39.5954 59.3931 
gel 
(hexagonal) 
2.4654 0.0524 1.4792 0.9862 2.0615 39.1675 58.7513 
gel 
(hexagonal) 
2.4273 0.0765 1.4564 0.9709 3.0251 38.7779 58.1668 Two phases 
2.4023 0.1015 1.4414 0.9609 4.0151 38.3784 57.5676 Two phases 
2.3796 0.1257 1.4278 0.9518 5.2824 37.9931 56.9896 Two phases 
 
Set #16 (37.5% Water+ 62.5% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.5625 0.9375 0.0000 37.5000 62.5000 Two phases 
2.4760 0.0253 1.5475 0.9285 1.0006 37.1207 61.8678 Two phases 
2.4654 0.0524 1.5409 0.9245 2.0615 36.7196 61.1993 Two phases 
2.4273 0.0765 1.5171 0.9103 3.0251 36.3543 60.5904 Two phases 
2.4023 0.1015 1.5014 0.9008 4.0151 35.9798 59.9663 Two phases 
2.3796 0.1257 1.4873 0.8924 5.1703 35.6185 59.3641 Two phases 
 
Set #17 (35% Water+ 65% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.6250 0.8750 0.0000 35.0000 65.0000 Two phases 
2.4740 0.0256 1.6081 0.8659 1.0131 34.6415 64.3343 Two phases 
2.4629 0.0528 1.6009 0.8620 2.0791 34.2654 63.6358 Two phases 
2.4272 0.0767 1.5777 0.8495 3.0328 33.9279 63.0089 Two phases 
2.4026 0.1018 1.5617 0.8409 4.0253 33.5773 62.3579 Two phases 
2.3799 0.1264 1.5469 0.8330 5.3111 33.2348 61.7219 Two phases 
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Set #18 (32.5% Water+ 67.5% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.6875 0.8125 0.0000 32.5000 67.5000 
Inverse 
micelles 
2.4781 0.0254 1.6727 0.8054 1.0041 32.1703 66.8152 
Inverse 
micelles 
2.4697 0.0516 1.6670 0.8027 2.0273 31.8349 66.1186 
Inverse 
micelles 
2.4257 0.0756 1.6373 0.7884 2.9905 31.5177 65.4599 Two phases 
2.4062 0.1023 1.6242 0.7820 4.0406 31.1746 64.7473 Two phases 
2.3784 0.1256 1.6054 0.7730 5.2821 30.8694 64.1134 Two phases 
 
Set #19 (30% Water+ 70% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.7500 0.7500 0.0000 30.0000 70.0000 
Inverse 
micelles 
2.4781 0.0254 1.7347 0.7434 1.0041 29.6956 69.2898 
Inverse 
micelles 
2.4697 0.0516 1.7288 0.7409 2.0273 29.3860 68.5674 
Inverse 
micelles 
2.4257 0.0756 1.6980 0.7277 2.9905 29.0933 67.8843 
Inverse 
micelles 
2.4062 0.1023 1.6843 0.7219 4.0406 28.7766 67.1453 Two phases 
2.3784 0.1256 1.6649 0.7135 5.2821 28.4949 66.4880 Two phases 
 
Set #20 (25% Water+ 75% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 1.8750 0.6250 0.0000 25.0000 75.0000 
Inverse 
micelles 
2.4490 0.0252 1.8368 0.6123 1.0065 24.7454 74.2361 
Inverse 
micelles 
2.4552 0.0548 1.8414 0.6138 2.1634 24.4542 73.3625 
Inverse 
micelles 
2.4273 0.0778 1.8205 0.6068 3.0740 24.2236 72.6708 Two phases 
2.4063 0.1036 1.8047 0.6016 4.0917 23.9681 71.9043 Two phases 
2.3768 0.1257 1.7826 0.5942 5.2874 23.7445 71.2336 Two phases 
 
Set #21 (20% Water+ 80% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 2.0000 0.5000 0.0000 20.0000 80.0000 
Inverse 
micelles 
2.4745 0.0256 1.9796 0.4949 1.0125 19.7952 79.1808 
Inverse 
micelles 
2.4544 0.0540 1.9635 0.4909 2.1337 19.5694 78.2778 Two phases 
2.4243 0.0764 1.9394 0.4849 3.0235 19.3890 77.5559 Two phases 
2.4025 0.1026 1.9220 0.4805 4.0587 19.1809 76.7235 Two phases 
2.3798 0.1254 1.9038 0.4760 5.2694 18.9989 75.9955 Two phases 
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Set #22 (15% Water+ 85% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 2.1250 0.3750 0.0000 15.0000 85.0000 
Inverse 
micelles 
2.4745 0.0257 2.1033 0.3712 1.0162 14.8458 84.1263 
Inverse 
micelles 
2.4544 0.0546 2.0862 0.3682 2.1558 14.6738 83.1516 Two phases 
2.4243 0.0765 2.0607 0.3636 3.0278 14.5413 82.4005 Two phases 
2.4025 0.1016 2.0421 0.3604 4.0174 14.3914 81.5513 Two phases 
2.3798 0.1265 2.0228 0.3570 5.3168 14.2427 80.7088 Two phases 
 
Set #23 (10% Water+ 90% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 2.2500 0.2500 0.0000 10.0000 90.0000 
Inverse 
micelles 
2.4720 0.0254 2.2248 0.2472 1.0064 9.8983 89.0846 
Inverse 
micelles 
2.4530 0.0519 2.2077 0.2453 2.0525 9.7928 88.1353 Two phases 
2.4262 0.0756 2.1836 0.2426 2.9886 9.6978 87.2804 Two phases 
2.4062 0.1034 2.1656 0.2406 4.0847 9.5880 86.2918 Two phases 
2.3777 0.1252 2.1399 0.2378 5.2656 9.4998 85.4980 Two phases 
 
Set #24 (5% Water+ 95% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 2.3750 0.1250 0.0000 5.0000 95.0000 
Inverse 
micelles 
2.4570 0.0255 2.3342 0.1229 1.0161 4.9486 94.0242 
Inverse 
micelles 
2.4570 0.0526 2.3342 0.1229 2.0759 4.8952 93.0088 Two phases 
2.4256 0.0768 2.3043 0.1213 3.0406 4.8465 92.0844 Two phases 
2.4004 0.1002 2.2804 0.1200 3.9675 4.7996 91.1933 Two phases 
2.3746 0.1251 2.2559 0.1187 5.2683 4.7498 90.2456 Two phases 
 
Set #25 (0% Water+ 100% Tween 80) 
Mixture 
(gm) 
Terb. 
(gm) 
Tween 
(gm) Water (gm) %Terb. %Water 
%Tween 
80 Phase status 
2.5000 0.0000 2.5000 0.0000 0.0000 0.0000 100.0000 Single phase 
2.4740 0.0254 2.4740 0.0000 1.0061 0.0000 98.9838 Two phases 
2.4605 0.0505 2.4605 0.0000 1.9912 0.0000 97.9888 Two phases 
2.4283 0.0757 2.4283 0.0000 2.9910 0.0000 96.9768 Two phases 
2.4018 0.1026 2.4018 0.0000 4.0592 0.0000 95.9032 Two phases 
2.3787 0.1258 2.3787 0.0000 5.2886 0.0000 94.9770 Two phases 
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PHASE DIAGRAM OF WATER, TWEEN 80 AND TERBINAFINE HCl 
 
 
 
 
        Terbinafine HCl          
                       
         10% 90%   10% 90%         
                       
        20% 80%     20% 80%        
                       
       30% 70%       30% 70%       
                       
      40% 60%         40% 60%      
 Two phases                    
     50% 50%           50% 50%     
                       
    60% 40%             60% 40%    
                       
   70% 30%               70% 30%   
                       
  80% 20%                 80% 20%  
                       
 ## 10%                   90% 10% 
                       
                       
 Water 90%  80%  70%  60%  50%  40%  30%  20%  10%  Tween 80 
   10%  20%  30%  40%  50%  60%  70%  80%  90%    
      Micelles     Hexagonal LC Inverse micelles    
 Figure [3-6]: Phase diagram of Water- Terbinafine - and Tween 80.   
                       
 3-6-1-Phase Diagram Result            
                       
 From the diagram shown above, it is clear the solubility regions of   
 Terbinafine HCl. The solubility arrived up to 3.0% at three points ;   
 (68% water and 29% tween 80 at micelles region.       
 (46% water, 51% tween 80), at hexagonal region.       
 (29% water, 68% tween 80) at inverse micelles region      
 In addition to other soluble regions of 1% and 2% of Terbinafine HCl. 
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4-Conclusion 
  
The Terbinafine HCl cream formula was developed, it was selected from about 18 
formulas by using GMS (SE), cetostearyl alcohol and Eumulgin B2 as emulsifiers, 
chloro-cresol was used as the preservative, in addition to the emollient; paraffin oil, and 
the oil base; Vaseline.  The pH   is adjusted by TEA for about 4.6 to be equivalent to the 
brand product Lamisil. O/W technique was used to get less greasy product. The mixing 
speed was found 80 -120 rpm to get the best results using Erweka mixer. There was no 
effect for the addition temperature of terbinafine to the cream between  50 – 70 c. 
 
The formula was put under accelerated stability study for six months, no significant 
chemical, physical, microbial or pharmaceutical change occurred. The study condition 
was at temperature of 40 c° and a humidity of 75% for 1,2,3 and six months followed by 
complete analysis 
 
The methods of analysis were developed and applied on the selected formula. It 
depended on the HPLC technique as the separation method using RP18 as a stationary 
phase and methanol and acetate buffer (95: 5 respectively) as the mobile phase, UV 
detector was used for detection purpose. The method of analysis (assay) passed the 
analytical validation process for all factors tried (accuracy, precision, linearity, and 
ruggedness). The method at the same time can be used for preservative potency 
determination in the product.  
  
Penetration of the cream is compared with that for the brand product „Lamisil‟ by using 
the Franz diffusion cell. The two formulas have approximately the same penetration 
profile.  
 
Solubility of Terbinafine HCl was determined in water and tween 80 and in mixtures of 
the two solvents using phase diagram technique. It was found that it is slightly soluble 
in both solvents (water and tween 80), but soluble in some concentrations up  to 3% at 
three different compositions (68%water:29%tween, 46% water: 51% tween, 29% water: 
68% tween). The drawn phase diagram showed the Terbinafine soluble regions in 
addition to the other regions such as the micelles, hexagonal and inverse micelles 
regions. 
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ملخص‏البحث‏
‏
تيربنافين‏ىايدروكلورايد‏الذي‏ينتمي‏إلى‏عائلة‏أليل‏أمين‏قد‏ركب‏في‏مستحضر‏كريم‏ليكون‏مكافئاً‏كمياً‏ونوعياً‏إلى‏
الدادة‏الفعالة‏ىي‏تيربنافين‏ىايدروكلورايد‏والتي‏ىي‏مادة‏.‏الذي‏تنتجو‏شركة‏نوفارتيز‏السويسرية‏)لاميسيل(الدستحضر‏الأم‏
إن‏طريقة‏إيجاد‏كمية‏الدادة‏الفعالة‏في‏الدستحضر‏قد‏طورت‏وأجري‏لذا‏عملية‏التثبت‏من‏.‏واسعة‏الفعالية‏ضد‏الفطريات
وكذلك‏الانتقائية‏ومدى‏الخطية‏ومدى‏مرونة‏.‏خلال‏فحص‏مدى‏دقة‏الطريقة‏ومدى‏قرب‏كمية‏الدادة‏الفعالة‏إلى‏الحقيقة
.‏الطريقة‏إلى‏بعض‏العوامل‏الدؤثرة
‏
إن‏تيربنافين‏ىايدروكلورايد‏قليل‏الذائبية‏في‏.‏لقد‏درست‏ثباتية‏التركيبة‏الدختارة‏وقورنت‏نفاذية‏الدواء‏مع‏نفاذية‏دواء‏لاميسيل
.‏‏من‏خلال‏بناء‏مثلث‏حالات‏الدادة08الداء،‏لذلك‏ذوبت‏الدادة‏بخليط‏من‏الداء‏ومادة‏توين‏
‏
التجارب‏أجريت‏.‏لقد‏أجريت‏عدة‏تجارب‏لتطوير‏كريم‏ذو‏تركيبة‏ثابتة‏وفعالة‏بالإضافة‏إلى‏نقاءه‏والأمان‏في‏استعمالو
:‏باتجاىين
‏
.‏والدواد‏الحافظة‏)التي‏تعمل‏علل‏اامع‏بين‏الزيوت‏والداء‏معاً‏‏(اختيار‏الدواد‏الدناسبة‏كماً‏ونوعاً‏خصوصاً‏الدستحلبات:‏أولاً‏
‏
.‏التغيير‏في‏طريقة‏الخلط:‏ثانياً‏
إنو‏من‏الدهم‏إنتاج‏كريماً‏لو‏مواصفات‏مطابقة‏لدواصفات‏الدستحضر‏الأم،‏من‏النواحي‏الصيدلانية‏والكيميائية‏
كثير‏من‏الدستحلبات‏قد‏جربت‏لوحدىا‏أو‏بإضافة‏أثنين‏معاً‏أو‏أكثر‏مثل‏.‏والدايكروبيولوجية،‏بالإضافة‏إلى‏النواحي‏الفيزيائية
في‏.‏‏وسيتوستيريل‏الكحول،‏وذلك‏بتجربة‏كل‏الاحتمالات‏لاستعمالذم‏معاً‏2بوأملجن‏‏)ذاتي‏الفعالية(جلسريل‏مونوستيريت
التغيير‏أيضاً‏في‏خطوات‏العمل‏مثل‏التغيير‏في‏.‏نفس‏الوقت‏كثير‏من‏التجارب‏قد‏أجريت‏لاختيار‏أفضل‏وأأمن‏مادة‏حافظة
وكذلك‏التغيير‏في‏درجة‏حرارة‏الكريم‏قبل‏إضافة‏الدادة‏الفعالة‏.‏‏دورة‏في‏الدقيقة081‏‏و021‏،08،‏02سرعة‏الخلط‏ليكون‏‏
‏‏    .(07 ،06 ‏،05(لو‏
‏
لا‏يوجد‏مصادر‏متوفرة‏لتحليل‏تيربنافين‏ىايدروكلورايد‏في‏الدراجع‏العالدية‏مثل‏الدرجع‏البريطاني‏أو‏الأوروبي‏أو‏الأمريكي،‏
.‏لذلك‏إنو‏من‏الضروري‏والأساسي‏لتطوير‏طريقة‏التحليل‏للمادة‏الفعالة‏الخام‏وللمستحضر‏أيضاً‏
‏
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فيو‏العمود‏الذي‏يحمل‏الدادة‏الثابتة‏يحتوي‏علل‏مادة‏غير‏قطبية‏،‏لقد‏طورت‏طريقة‏تحليل‏تعتمد‏علل‏الفصل‏الكروماتوغرافي
‏.اسيتات‏من‏المحلول‏الدتعادل%‏5وميثانول‏%‏59وفيو‏ايضا‏الدادة‏الدتحركة‏
‏
‏لقد‏تم‏التثبت‏من‏طريقة‏التحليل‏للتأكد‏من‏أن‏الطريقة‏مضمونة‏وتعمل‏بشكل‏ثابت‏لإيجاد‏كمية‏الدادة‏الفعالة‏في‏
:‏لقد‏فحصت‏خمسة‏من‏العوامل‏ذات‏العلاقة‏في‏التثبت‏وىي.‏الدستحضر
‏
كل‏تشغيلة‏حللت‏.‏مدى‏قرب‏النتيجة‏إلى‏الحقيقة،‏وذلك‏من‏خلال‏حساب‏النتيجة‏لثلاث‏تشغيلات‏مختلفة -
 .ثلاث‏مرات،‏وفي‏كل‏مرة‏يتم‏تحليل‏خمس‏عينات،‏ثم‏يحسب‏الدعدل‏للنتائج‏وتقارن‏مع‏القيمة‏الحقيقية
‏
مدى‏الدقة‏في‏الطريقة‏قد‏فحصت‏أيضا‏من‏خلال‏حساب‏معامل‏التغير‏لثلاث‏تشغيلات‏مختلفة،‏كل‏تشغيلة‏ -
 .حللت‏ثلاث‏مرات،‏وفي‏كل‏مرة‏يتم‏تحليل‏خمس‏عينات
 
وتم‏تحديد‏ذلك‏بإجراء‏.‏الانتقائية‏أيضاً‏حددت‏لضمان‏عدم‏تداخل‏مواد‏أخرى‏من‏مواد‏التركيبة‏في‏التحليل -
 .الفحص‏بغياب‏الدادة‏الفعالة‏في‏الدستحضر
 
تم‏.‏مدى‏مقاومة‏الطريقة‏للعوامل‏الدؤثرة‏قد‏فحصت‏للتأكد‏أن‏الطريقة‏تعمل‏تحت‏ظروف‏مختلفة‏بنفس‏الكفاءة -
وعلل‏عدة‏درجات‏حرارة‏‏)‏دقيقة081‏و‏51‏(حساب‏ذلك‏من‏خلال‏إبقاء‏المحاليل‏المحضرة‏علل‏أوقات‏مختلفة‏
.‏وحدد‏أيضاً‏مدى‏تأثير‏استعمال‏عمودين‏مختلفين‏لذما‏نفس‏الدواصفات.‏‏لثلاث‏تشغيلات‏مختلفة)‏04‏و‏02(
 .ثم‏تم‏حساب‏مدى‏الدقة‏ومدى‏قرب‏النتيجة‏من‏الحقيقة‏لكل‏العينات‏التي‏تم‏تحليلها
لقد‏تم‏تحديد‏.‏مدى‏خطية‏الطريقة‏قد‏حددت‏أيضاً‏للتأكد‏من‏أن‏النتيجة‏تزداد‏بنفس‏قيمة‏ازدياد‏تركيز‏العينة -
‏من‏تركيز‏العينة‏اااىزة‏%)051،‏%521،‏%001،‏%57،‏%05(مدى‏الخطية‏من‏خلال‏تحليل‏خمسة‏تركيز‏مختلفة‏
 .وتم‏إجراء‏رسم‏بياني‏بالاعتماد‏علل‏برنامج‏اكسل‏لحساب‏معامل‏الارتباط‏للخط‏الدستقيم‏الدرسوم.‏للفحص
‏
تم‏.‏لقد‏تم‏التأكد‏من‏ثباتية‏التركيبة‏النهائية‏الدختارة‏للكريم،‏حيث‏تم‏الاعتماد‏علل‏دراسة‏ثباتية‏مسّرعة‏لددة‏ستة‏أشهر
اتبعت‏بتحاليل‏شاملة‏،‏‏لددة‏شهر،‏شهرين‏،‏ثلاثة‏أشهر‏وستة‏أشهر%57‏‏ورطوبة‏‏54حفظ‏الكريم‏علل‏درجة‏حرارة‏
.‏للتأكد‏من‏غياب‏أي‏تغير‏كيميائي،‏فيزيائي‏أو‏ميكروبيولوحي‏للمستحضر
‏
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فرانس‏"باستعمال‏‏)لاميسيل(تم‏دراسة‏مدى‏نفاذية‏الدواء‏إلى‏االد‏وذلك‏من‏خلال‏مقارنة‏بينو‏وبين‏نفاذية‏الدواء‏الأم
.‏‏وقد‏وجد‏أنو‏يوجد‏تطابق‏كبير‏بين‏نفاذية‏الدوائين ".)دفيوجن‏سل
‏
‏من‏خلال‏استخدام‏تكنيك‏مثلث‏حالة‏الدادة‏وذلك‏08تمت‏دراسة‏ذائبية‏تيربنافين‏ىايدروكلورايد‏في‏خليط‏من‏الداء‏و‏توين‏
العديد‏من‏التجارب‏قد‏أجريت‏استخدم‏خلالذا‏تراكيز‏مختلفة‏من‏الدواد‏.‏08بإضافة‏الدادة‏الفعالة‏مع‏مزيج‏من‏الداء‏و‏توين‏
‏غرام‏من‏الخليط،‏5,2يقارب‏‏مل،‏حضر‏في‏كل‏منها‏ما‏5،‏وتم‏تحضير‏العينات‏في‏أنابيب‏)08تيربنافين،‏ماء،‏توين‏‏(الثلاث‏
تركت‏العينات‏لتهدأ‏وتصفل‏وتم‏.‏‏ساعة42‏لددة‏52واتبع‏ذلك‏بخلط‏جيد‏ووضع‏علل‏جهاز‏التراسونيك‏وحفظ‏علل‏درجة‏حرارة‏
الدخلوط‏الذي‏فيو‏تعكير‏أو‏رواسب‏اعتبر‏غير‏نقي،‏وفي‏نفس‏الوقت‏الدساحات‏في‏الدثلث‏حددت‏.‏فحص‏مدى‏نقاوتها
.‏‏في‏ىذا‏النظامدمواقع‏الدادة‏الفعالة‏الذائبة‏ومواقع‏اال‏أيضاً‏وتبين‏جلياً‏حدود‏الذائبية‏للتيربنافين‏ىايدروكلوراي
‏
بالنسبة‏للنواحي‏الكيميائية،‏الفيزيائية،‏‏)لاميسيل(لقد‏تم‏إنتاج‏تركيبة‏جيدة‏للكريم‏وىي‏تكافئ‏مواصفات‏الدواء‏الأم
،‏2،‏اموان‏ب)ذاتي‏الفعالية(تم‏اختيار‏ثلاثة‏مستحلبات‏معاً‏وىي‏جلسريل‏مونو‏ستيريت‏.‏)الديكروبيولوجية‏والصيدلانية
‏الكحول،‏الدادة‏الحافظة‏الدستعملة‏ىي‏كلوروكريسول‏التي‏كانت‏فعالة‏ضد‏الديكروبات‏الوارد‏فحصها‏في‏دستور‏لوسيتوستيري
.‏الأدوية‏الأمريكي
‏
‏إلى‏08ووجد‏أيضاً‏أن‏أفضل‏سرعة‏كانت‏بين‏.‏أما‏بقية‏الدواد‏الحافظة‏فقد‏فشلت‏في‏فعاليتها‏أو‏أنها‏تسببت‏في‏بعض‏الدشاكل‏في‏التحليل
‏أو‏05إن‏إضافة‏الدادة‏الفعالة‏علل‏درجة‏حرارة‏.‏‏دورة‏في‏الدقيقة‏لدنع‏دخول‏الذواء‏أو‏حدوث‏فصل‏ما‏بين‏الطبقة‏الدائية‏والطبقة‏الزيتية021
‏‏درجة‏مئوية‏لم‏يظهر‏أي‏فرق‏بين‏الحالات‏الثلاث،‏لذلك‏يمكن‏استنتاج‏أن‏تيربنافين‏ىايدروكلورايد‏ثابت‏كيميائياً‏عند‏درجة‏07‏أو‏‏06
.‏‏درجة‏مئوية07حرارة‏
‏
ووجد‏أيضاً‏أن‏التركيبة‏ثابتة‏تحت‏الظروف‏القاسية‏التي‏تم‏دراستها‏عند‏درجة‏.‏إن‏طريقة‏التحليل‏وجدت‏ثابتة‏لكل‏العوامل‏التي‏تمت‏دراستها
.‏لذلك‏يمكن‏اعتبار‏الدستحضر‏صالح‏لددة‏سنتين.‏‏النسبيةالرطوبة%‏57‏و‏04حرارة‏
‏
وتبين‏من‏خلال‏.‏‏مل‏من‏الدذيب001/غم1،‏وتبين‏أنو‏قليل‏الذائبية‏في‏كليهما‏أي‏أقل‏من‏08‏لقد‏تم‏تحديد‏ذائبية‏تيربنافين‏في‏الداء‏و‏توين‏
بالإضافة‏إلى‏ظهور‏مواقع‏للجل‏وأخرى‏%‏0.3مثلث‏حالة‏الدادة‏مواقع‏ذائبية‏تيربنافين‏في‏معظم‏الدساحات‏التي‏يقل‏فيها‏تركيز‏الدادة‏عن‏
 .بالإضافة‏الى‏مناطق‏أخرى‏مثل‏الدايسلز‏والانفرز‏مايسلز‏)مزيج‏واحدأي‏مادتان‏منفصلتان‏في‏(للعينات‏التي‏فيها‏راسب‏
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